Document:

EX-10.5

 Exhibit 10.5 

CONTRACT MANUFACTURING AGREEMENT 

This Contract Manufacturing Agreement (this “Agreement”) is made and entered into as of March 31, 2022, with effectiveness as
of 12:01 a.m., New York City time, on April 1, 2022 (the “Effective Date”) by and between Becton, Dickinson and Company, a New Jersey corporation (“BD”), and Embecta Corp., a Delaware corporation
(“SpinCo”). Parent and SpinCo are sometimes referred to herein individually as a “Party” and collectively as the “Parties.” 

RECITALS 
 WHEREAS,
the board of directors of BD (the “BD Board”) has determined that it is in the best interests of BD and its shareholders to create a new publicly traded company that will operate its diabetes care business (the “DC
Business”); 
 WHEREAS, in furtherance of the foregoing, the BD Board has determined that it is appropriate and desirable to
separate the DC Business from the other businesses of BD (the “Separation”) and, following the Separation, make a distribution, on a pro rata basis, to shareholders of BD of all of the outstanding shares of capital stock of SpinCo
owned by BD (the “Distribution”); 
 WHEREAS, SpinCo has been incorporated solely for these purposes and has not
engaged in any activities except in connection with the Separation and the Distribution; 
 WHEREAS, each of BD and SpinCo has
determined that it is appropriate and desirable to set forth certain agreements that will govern certain matters relating to the Separation and the Distribution and the relationship of BD, SpinCo and their respective affiliates following the
Distribution; and 
 WHEREAS, to facilitate the prompt assumption by Customer of all manufacturing activities for the Products,
Supplier shall supply the Products and provide related services and manufacturing activities for Customer for a transitional period, subject to the terms and conditions set forth herein. 

NOW, THEREFORE, in consideration of the foregoing and the covenants and promises contained herein, the receipt and sufficiency of which
is hereby acknowledged, the Parties hereby agree as follows: 
 1. DEFINITIONS 

Capitalized terms used but not defined herein shall have the meaning given to such terms in the Separation and Distribution Agreement. The
following capitalized terms shall have the following meanings as used in this Agreement: 
 1.1 “Agreement” has the meaning
set forth in the Preamble. 
 1.2 “Binding Commitment” has the meaning set forth in the Statement of Work. 

 

 1.3 “Business Day” means (a) any day other than a Saturday, Sunday or
a day on which banking institutions are authorized or obligated by law to be closed in New York, New York or (b) any day other than any day on which banking institutions are authorized or obligated by law to be closed in the country in which
the Facility is located. 
 1.4 “cGMP” means the then-current Good Manufacturing Practices as defined by the FDA in Title 21
of the Code of Federal Regulations. 
 1.5 “Change of Control” means with respect to a Party, (a) a merger or
consolidation of such Party with a third party that results in the voting securities of such Party outstanding immediately prior thereto, or any securities into which such voting securities have been converted or exchanged, ceasing to represent at
least fifty percent (50%) of the combined voting power of the surviving entity or the parent of the surviving entity immediately after such merger or consolidation, (b) a transaction or series of related transactions in which a third party,
together with its Affiliates, becomes the beneficial owner of fifty percent (50%) or more of the combined voting power of the outstanding securities of such Party, or (c) the sale or other transfer to a third party, directly or indirectly, of
all or substantially all of such Party’s assets or business to which the subject matter of this Agreement relates. 
 1.6
“Claim” has the meaning set forth in Section 10.3. 
 1.7 “Complaint” means any
written or oral expression or dissatisfaction relative to the identity, quality, durability, reliability, safety, effectiveness, or performance of a Product including, but not limited to, actual or suspected Product tampering, contamination,
mislabeling, or wrong components. 
 1.8 “Conforming Purchase Order” means a Purchase Order for a given Month that
(a) specifies the quantity of Product, by SKU, as set forth for the first Month of the then-current Rolling Forecast Binding Commitment, (b) otherwise complies with the terms of this Agreement, including specifying Product quantities by
SKU that, for each Product SKU (i) are equal to or greater than the Monthly Period Product Quantity Minimum, (ii) are integer multiples of the Minimum Lot Size, and (iii) are no greater than the applicable Monthly Period Product
Quantity Cap, and (c) specifies a required delivery date that is no earlier than the last day of the Month to which such Purchase Order applies. For the avoidance of doubt, an internal order between the Parties while SpinCo is under the
Transition Services Agreement and Logistics Services Agreement shall be deemed a Purchase Order hereunder. 
 1.9 “Customer”
means [BD and its designated subsidiaries] OR [SpinCo and its designated subsidiaries], as applicable. 
 1.10
“Effective Date” has the meaning set forth in the Preamble. 
 1.11 “Facility” has the meaning set forth in
the Statement of Work. 
 1.12 “FDA” means the United States Food and Drug Administration. 

  
 2 

 1.13 “FDA Approval” means, in respect of the Products, all necessary
Regulatory Approvals granted by the FDA for the manufacture, sale and distribution of the Products in the United States. 
 1.14
“Field Action” has the meaning set forth in Section 9.1. 
 1.15 “Fiscal Year”
means each twelve (12)-Month period between October 1st and September 30th, provided that (a) the first “Fiscal Year” of the Term will commence on the Effective Date and end on the first occurrence of September 30th thereafter
and (b) the final “Fiscal Year” of the Term will end on the termination of this Agreement. As used in this Agreement, “Year 1” shall mean the first Fiscal Year of the Term, “Year 2” shall mean the second Fiscal
Year of the Term, and so forth. 
 1.16 “Fixed Assets” has the meaning set forth in the Statement of Work. 

1.17 “Force Majeure Event” has the meaning set forth in Section 14.8. 

1.18 “Governmental Authority” means any nation or government, any state, municipality or other political subdivision thereof,
and any entity, body, agency, commission, department, board, bureau, court, tribunal or other instrumentality, whether federal, state, local, domestic, foreign or multinational, exercising executive, legislative, judicial, taxing, regulatory,
administrative or other similar functions of, or pertaining to, government and any executive official thereof. 
 1.19
“Implementation Plan” has the meaning set forth in Section 7.4. 
 1.20 “Inspection
Period” has the meaning set forth in Section 4.4(a). 
 1.21 “Labeling Modifications” has
the meaning set forth in Section 8.1. 
 1.22 “Losses” has the meaning set forth in
Section 10.1. 
 1.23 “Maximum Allowance Purchase Cap” has the meaning set forth in the Statement
of Work. 
 1.24 “Minimum Lot Size” has the meaning set forth in the Statement of Work. 

1.25 “Month” means a calendar month; provided that the first Month shall commence on the Effective Date and shall end
on the last day of the Month in which the Effective Date occurs. 
 1.26 “Monthly Period Product Quantity Cap” has the
meaning set forth in Section 2.2. 
 1.27 “Monthly Period Product Quantity Minimum” has the
meaning set forth in Section 2.2. 
 1.28 “New Manufacturing Process” means a manufacturing
process introduced by Supplier into the manufacture of the Products after the Effective Date without either of (i) Customer’s written request for such manufacturing process or (ii) Customer’s written approval of such manufacturing
process. 

  
 3 

 1.29 “Non-Conforming Purchase
Order” has the meaning set forth in Section 4.2(c). 
 1.30 “Party” or
“Parties” has the meaning set forth in the Preamble. 
 1.31 “Pricing Principles” has the meaning set forth
in Schedule [ ] under the heading “Pricing Principles”. 
 1.32 “Product Group” has the meaning set forth in the
Statement of Work. 
 1.33 “Product Price” has the meaning set forth in Section 3.1. 

1.34 “Products” shall mean the products listed by SKU in the Statement of Work. 

1.35 “Purchase Order” means a firm, written order for manufacturing and delivery of Products submitted by Customer to
Supplier. 
 1.36 “Purchased Inventory” means all inventory of finished Products under the heading entitled “Purchased
Inventory” in the Statement of Work. 
 1.37 “Raw Materials” means all raw materials used to make the Product. 

1.38 “Regulatory Approval” means any and all clearances and approvals (including supplements, amendments, label expansions, pre- and post- approvals), licenses, registrations, or authorizations of any Governmental Authority that are necessary for the manufacture, distribution, use, and sale of the Products in a regulatory jurisdiction
and, for the purpose of the United States, means FDA Approval. 
 1.39 “Rejection Notice” has the meaning set forth in
Section 4.4(a). 
 1.40 “Representative(s)” means (a) with respect to Supplier: Supplier, its
affiliates and each of their respective officers, directors, employees, consultants, contractors and agents, in each case to the extent designated by Supplier to perform all or any portion of its obligations under this Agreement, and (b) with
respect to Customer: Customer, its affiliates and each of their respective officers, directors, employees, consultants, contractors and agents, in each case to the extent authorized to receive any Product on behalf of Customer or perform any of
Customer’s obligations under this Agreement. 
 1.41 “Rolling Forecast” has the meaning set forth in
Section 4.1. 
 1.42 “Rolling Forecast Change Parameter” has the meaning set forth in
Section 4.1(a). 
 1.43 “Semi-Binding Commitment” has the meaning set forth in the Statement of
Work. 
 1.44 “Separation and Distribution Agreement” has the meaning set forth in the Recitals. 

  
 4 

 1.45 “SKU” means, with respect to each Product, such Product’s stock
keeping unit identifier as identified on the Statement of Work under the heading “[Products]”. 
 1.46
“Specifications” means the specifications for the Products by SKU set forth in the Statement of Work under the heading “[Specifications]”. 

1.47 “Statement of Work” means the terms and conditions set forth in Exhibit A hereto. 

1.48 “Sterilization” means the administration of an agreed upon anti-microbial process. 

1.49 “Supplier” means [BD and its designated subsidiaries] OR [SpinCo and its designated subsidiaries] as
applicable. 
 1.50 “Term” has the meaning set forth in the Statement of Work. 

1.51 “Withholding Agent” has the meaning set forth in Section 3.4. 

2. PURCHASE AND SUPPLY 
 2.1
Purchase and Supply. During the applicable Term, Customer agrees to purchase from Supplier, and Supplier agrees to supply to Customer, Products (and, if applicable, related services) in such quantities as may be ordered by Customer pursuant
to Purchase Orders as provided in Section 4.2 below (subject, in each case, to the limitations and requirements of Section 2.2), and at such prices as provided in the Statement of Work. 

2.2 Order Minimums and Maximums. In accordance with the provisions of Section 4 below, Customer shall place
Purchase Orders with Supplier for any given month for an amount of units of Product not less than the amount set forth in the Statement of Work under the heading “Monthly Period Product Quantity Minimum” (the “Monthly Period
Product Quantity Minimum”) and not more than the amount set forth in the Statement of Work under the heading “Monthly Period Product Quantity Cap” (the “Monthly Period Product Quantity Cap”). Notwithstanding any
provision of this Agreement to the contrary, except as mutually agreed by the Parties in writing pursuant to Section 4.2(c), Supplier shall not during any twelve (12)-month period, be required to supply any quantity of any
Product Group or Product SKU, as applicable, that is greater than the amount set forth in the Statement of Work under the heading “Yearly Period Product Quantity Cap” for such Product Group or Product SKU, as applicable (the
“Yearly Period Product Quantity Cap”). For the avoidance of doubt, the Purchased Inventory purchased by Customer under this Agreement shall not count towards any Monthly Period Product Quantity Minimum, any Monthly Period Product
Quantity Cap or any Yearly Period Product Quantity Cap. 
 2.3 Manufacturing Activities. Except as otherwise contemplated by the
Statement of Work, Supplier shall be responsible for the procurement of Raw Materials and the manufacturing, labeling, assembly, packaging and Sterilization (if applicable) in accordance with the applicable Specifications, and delivery of Products
in accordance with the Statement of Work. 

  
 5 

 2.4 Performance through Representatives. Except as otherwise contemplated by the
Statement of Work, Customer acknowledges and agrees that Supplier will at the Effective Date be performing and may continue to perform all or part of its obligations under this Agreement itself or through one or more of its Representatives or third
party contractors; provided, however, that if Supplier desires to perform any obligation under this Agreement (including Sterilization) through a Representative or third party contractor that is not performing such activity as
of the Effective Date, then Supplier shall first obtain Customer’s prior written consent, such consent not to be unreasonably withheld, delayed or conditioned; and, provided further, that Supplier shall remain responsible for any of its
obligations under this Agreement that are performed by its Representatives or third party contractors. For the avoidance of doubt, each Party’s right to assign this Agreement in whole or in part shall be subject to
Section 14.1. 
 2.5 Standards. Supplier shall (a) use reasonably qualified personnel in connection
with manufacturing the Products for Customer and perform such manufacturing activities in a competent and workmanlike manner consistent with prevailing industry standards and in material compliance with applicable laws, the terms of this Agreement,
the Statement of Work and the Specifications, and (b) obtain and maintain all material licenses, permits or approvals required by applicable laws in connection with the manufacture of Products for Customer, including permits related to the
Facility. Except as may be required to comply with applicable laws (in which case Supplier shall supply Customer with at least ninety (90) days advance written notice), Supplier shall not amend, change or supplement (i) the Specifications,
(ii) the processes and procedures for manufacturing the Products, or (iii) the Facility, in each case without Customer’s prior written consent. 

2.6 Excused Performance. Notwithstanding any provision of this Agreement to the contrary, Supplier shall have no obligation to
manufacture, sell or supply Products (whether at all or in such quantities as Customer submits in Purchase Orders) or to make deliveries hereunder, and shall not be in breach of this Agreement, to the extent Supplier is prevented from performing
such activities as a result of (a) Customer’s failure to perform its obligations under this Agreement, (b) Customer’s failure to reasonably promptly approve an alternative supplier of Raw Materials or service provider following
Supplier’s written request for such approval made either (i) pursuant to Section 2.4 or (ii) for purposes of complying with changes in applicable law. 

2.7 Capacity Increases. The Parties acknowledge and agree that for each Product Group and Produce SKU, as applicable, Supplier shall not
be required to supply an amount of Product in any Fiscal Year in excess of the amount set forth under the heading Maximum Allowable Purchase Cap in the Statement of Work. 

3. PRICING; BILLING 
 3.1
Pricing. For each unit of a Product SKU supplied by Supplier and delivered to Customer hereunder (with the exception of the Purchased Inventory), Customer shall pay to Supplier the corresponding per unit price set forth on the Statement of
Work (the “Product Price”), subject to adjustment in accordance with Section 3.2 and Section 8.1, and which shall take into account any adjustments resulting from changes in the
cost of manufacturing such Product as set forth in the Statement of Work. No consideration or amount shall be payable in respect of the Purchased Inventory. 

  
 6 

 3.2 Other Fees. Without limiting Customer’s obligations to pay or reimburse
Supplier for any costs set forth in this Agreement, Customer shall pay Supplier the fees described in this Section 3.2. 

(a) Non-Recurring Fees. Customer shall pay Supplier the following when and as the same are
incurred by Supplier: 
 (i) special, one-time or extraordinary costs incurred by Supplier to comply
with changes in applicable law (for the avoidance of doubt, to the extent allocable to the manufacturing, labeling, assembly, packaging, Sterilization (if applicable) and delivery of Products); provided that, to the extent permitted by
applicable law, Supplier shall provide Customer with prior written notice of such proposed additional costs, including a reasonably detailed description of such costs; 

(ii) all costs (including additional labor or third-party service charges) associated with the installation and testing of new capital
equipment ordered and installed pursuant to Section 7.3, including molds, molding presses, packaging and ancillary equipment in each case necessary for the continued manufacture of the Products during the Term (for the
avoidance of doubt, to the extent allocable to the manufacturing, labeling, assembly, packaging, Sterilization (if applicable) and delivery of Products); 

(iii) when and as the same are incurred by Supplier: (A) any
out-of-pocket costs and expenses incurred by Supplier in connection with inspections or audit by any Governmental Authority with respect to any Product, including any
audit fees charged by Governmental Authorities for audits or inspections of any Facility, in each case to the extent relating to the manufacture, assembly, packaging, labeling, Sterilization (if applicable) and delivery of any Product; and
(B) all out-of-pocket costs and expenses incurred by Supplier in connection with Field Actions or Complaints, to the extent such costs are not expressly required to
be borne by Supplier pursuant to Section 9; 
 (iv) where either (A) Supplier is required by applicable law
to obtain a new third party supplier of Raw Material or service provider or re-qualify an existing third party supplier or service provider, (B) a current supplier of Raw Material discontinues supplying
such Raw Materials, experiences a supply shortage, supply failure or force majeure event, or ceases to do business (whether by means of bankruptcy or otherwise), or (C) the Parties agree in writing that Supplier will obtain a new third party
supplier of Raw Material or service provider or re-qualify an existing third party supplier or service provider, in each case Customer shall reimburse Supplier for all costs in connection therewith (including
the costs of any new services, engineering fees and qualification costs); and 
 (v) any costs or expenses incurred by Supplier associated
with any delays caused by Customer, including delays caused by labeling changes pursuant to Section 8.  

3.3 Billing. Either within thirty (30) days after the end of each Month or upon delivery of Products, Supplier shall send Customer
one or more invoices setting forth in reasonable detail the aggregate amount owed by Customer to Supplier for Products delivered to Customer during such Month, with a breakdown showing: (a) the quantity of Products delivered to Customer during

  
 7 

 
such Month by Product SKU based on accepted Purchase Orders, pursuant to Section 4.5, or as otherwise mutually agreed, (b) the unit and aggregate Product Price for each Product,
(c) all applicable taxes (as a separate line item); and (d) any other amounts owed by Customer to Supplier under this Agreement that became due and payable during such Month. Customer shall pay Supplier within ninety (90) days of
receipt of the applicable invoice. 
 3.4 Taxes. All charges under this Agreement are exclusive of any taxes, including sales, use,
VAT, consumption, excise, withholding, or similar taxes (other than taxes based on Supplier’s or its affiliate’s net income) that may apply to the transactions contemplated by this Agreement. Customer shall be responsible for paying all
such taxes. Supplier may collect such Taxes from Customer as required by law. If any payments under this Agreement are subject to withholding or deduction, the applicable party (the “Withholding Agent”) shall be entitled to withhold
or deduct such amounts as required by applicable law, provided that prior to such withholding or deduction, the Withholding Agent shall give written notice of its intention to withhold or deduct and allow the other party sufficient time to
furnish any required documentations and forms to minimize or eliminate such withholding or deduction. The Withholding Agent shall pay all such withheld or deducted amounts to the applicable governmental authority. For the avoidance of doubt, the
provisions of this Section 3.4 shall apply to affiliates of Supplier and Customer as if such affiliate were Supplier or Customer, as applicable. 

4. ORDERS; DELIVERY; PERIODIC REVIEWS 

4.1 Forecasts. 
 (a) On or
before the fifteenth (15th) day of each Month, Customer shall furnish Supplier with a rolling forecast of the number of units of each Product (on a Product
Group-by-Product Group basis or Product SKU-by-SKU basis as set forth in the applicable
Statement of Work) that Customer reasonably expects to order for the following twelve (12) Months beginning with the following Month (the “Rolling Forecast”). The initial Rolling Forecast, which has been initially agreed by the
Parties, is attached to the applicable Statement of Work. Each Rolling Forecast must comply with Customer’s Monthly Period Product Quantity Minimum commitment with respect to each Product Group or Product SKU, as applicable and must forecast
quantities of Product in integer multiples of the Minimum Lot Size for each applicable Product Group or Product SKU, as applicable, but may not, for any forecasted Month, exceed the Monthly Period Product Quantity Cap with respect to any Product
Group or Product SKU, as applicable. Except as otherwise set forth in the Statement of Work, the first three (3) Months of each Rolling Forecast shall be binding upon Customer and Supplier (each, a “Binding Commitment”) and
each of Months four (4) through twelve (12) of each Rolling Forecast may be increased or decreased by Customer by no more than the percent set forth in the applicable Statement of Work (under the heading “Rolling Forecast Change
Parameter”) of the number of units of such Product (on a Product Group-by-Product Group basis or Product SKU-by-SKU basis as set forth on the applicable Statement of Work) for the same Month in the immediately preceding submitted Rolling Forecast (each, a “Semi-Binding Commitment”). To the
extent that a Rolling Forecast is not communicated by the Customer by fifteenth (15th) day of the then-current Month, the Parties agree that the Rolling Forecast for such Month shall be established by giving effect to the most recent Rolling
Forecast and substituting the remaining Months with the quantity set forth in the Monthly Period Product Quantity Cap for any remaining Months of the most recent Rolling Forecast, subject, in all cases, to the limitations and requirements set forth
in Section 2.2 and this Section 4.1. 

  
 8 

 (b) With respect to each Fiscal Year during the Term following Year 1, on or before
July 31 of the prior Fiscal Year, Customer shall submit to Supplier an initial forecast of orders by Product for such Fiscal Year, and shall be deemed to be the Rolling Forecast for the period starting on October 1 of such Fiscal Year and
ending on September 30 of such Fiscal Year. Supplier shall update each and every Product SKU pricing, consistent with the Pricing Principles, by August 31st prior to the upcoming Fiscal Year,
which shall be the pricing for the next Fiscal Year. Such updated price list shall be deemed to supersede and replace the prior pricing in each Statement of Work. The new pricing shall be effective on October 1 of the applicable Fiscal Year.

 4.2 Purchase Orders. 

(a) On the Effective Date, Customer shall place a Purchase Order for Products in the Purchased Inventory, which Customer shall acquire at no
cost. For clarity, no Purchased Inventory included in such initial Purchase Order shall be counted against any Monthly Period Product Quantity Minimum, Monthly Period Product Quantity Cap or Yearly Period Product Quantity Cap required hereunder, and
the Purchased Inventory shall not be subject to the Minimum Lot Size or considered part of any Rolling Forecast. 
 (b) Not less than thirty
(30) days prior to the first day of each Month, Customer shall submit a Conforming Purchase Order for the quantity of Products set forth for the first Month of the then-current Binding Commitment. All Conforming Purchase Orders shall become
binding on Supplier and Customer when received by Supplier, subject to Section 2.2. 
 (c) Customer may, from time
to time, in Customer’s discretion, place a Purchase Order for Products that is not a Conforming Purchase Order (a “Non-Conforming Purchase Order”). To the extent the quantity of a Product
set forth for any Month on a Non-Conforming Purchase Order (when combined with the quantity of such Product set forth in the Conforming Purchase Order for such Month submitted pursuant to
Section 4.2(b)) exceeds the Binding Commitment in such month or the Monthly Period Product Quantity Cap for such Product, the Parties will work together in good faith to attempt to meet Customer’s demand, subject to
capacity limitations, the availability of Raw Materials and the availability and capacity of Supplier’s third party service providers; provided that Supplier shall have no obligation to meet such additional demand or otherwise supply
Product pursuant to any Non-Conforming Purchase Order. Notwithstanding anything provided herein to the contrary, the Parties acknowledge that in the event that BD, as Customer hereunder, places a Conforming
Purchase Order to SpinCo, as Supplier hereunder, that SpinCo cannot satisfy solely based on BD’s inability or limitations to supply Raw Material under any Ancillary Agreement (taking into consideration, among other things, SpinCo’s ability
to procure the substantial equivalent of such Raw Materials from third parties), then SpinCo, as Supplier hereunder, shall not be in breach of this Agreement solely because of SpinCo’s inability to fulfil such Conforming Purchase Order, and
only for the duration of BD’s inability or limitations to supply Raw Material under any Ancillary Agreement, and the Parties shall work in good faith to resolve such issues. 

  
 9 

 (d) The terms and conditions of each Purchase Order (including any Conforming Purchase Order
and Non-Conforming Purchase Order) shall be consistent with this Agreement and the Statement of Work, and to the extent any Purchase Order, invoice, acknowledgment or other form used by Supplier or Customer
contains any provisions that are in addition to or contrary to the provisions of this Agreement or the Statement of Work, such additional or contrary provision shall have no force or effect and the terms of this Agreement or the Statement of Work,
as applicable, shall govern (unless otherwise agreed to by the Parties in writing). 
 (e) Any portion of or all of a Purchase Order
(including any Conforming Purchase Order and Non-Conforming Purchase Order) that is not submitted in accordance with this Agreement shall be deemed rejected by Supplier unless accepted by Supplier by written
notice provided by Supplier to Customer within fifteen (15) days of receipt by Supplier of such Purchase Order. For clarity, any rejected Purchase Order shall not constitute a Purchase Order in satisfaction of Customer’s obligation to
purchase the Monthly Period Product Quantity Minimum. 
 4.3 Delivery; Title; Risk of Loss. Delivery terms for Products shall be FCA
warehouse. Title and risk of loss of the Products shall pass to Customer upon receipt by Customer’s carrier. 
 4.4 Product
Inspection; Acceptance. 
 (a) Customer shall have the right to inspect any shipment of Products for damage, failure to provide the
quantity provided in a Purchase Order or other non-conformity with Supplier’s warranties set forth in Section 5.1, in each case at the time of delivery pursuant to
Section 4.3, within the period of sixty (60) days from the date of delivery of such Products (the “Inspection Period”), provided, however, with respect to any non-conformity with Supplier’s warranties set forth in Section 5.1 that is not reasonably detectable, the Inspection Period shall be extended to the date that is the earlier of
(a) fifteen (15) days after the date such non-conformity is first detected. Claims on account of non-conformity, loss or damage to Product shall be made by Customer
in writing within the applicable Inspection Period (a “Rejection Notice”). Any such Rejection Notice shall be accompanied by reasonable supporting evidence that shows that there was a default in the quantity of the Product delivered
to Customer by Supplier or that some or all of the Product delivered to Customer by Supplier was not manufactured in accordance with the applicable Specifications or otherwise breaches Supplier’s warranties set forth in
Section 5.1, in each case at the time of delivery pursuant to Section 4.3. If no Rejection Notice is delivered by Customer within the applicable Inspection Period, the Product shall be deemed
accepted by Customer. 
 (b) Customer’s sole remedy with respect to rejected Product shall be cancellation of the Purchase Order with
respect to the rejected Products and shipment of replacement Products in the same quantities as provided in the previously rejected Products Purchase Order. Supplier shall resupply any replacement Products within twelve (12) weeks of
Supplier’s receipt of an undisputed Rejection Notice; provided that, in each case, Supplier shall use commercially reasonable efforts to supply such replacement Products before the end of such twelve (12)-week period, to the extent
Supplier is able to do so based on Supplier’s available Raw Materials and manufacturing capacity. Supplier shall pay expenses related to the proper destruction of non-conforming Products to the extent
such expense is reasonably necessary. At Supplier’s written request, Customer shall return to Supplier, at Supplier’s sole cost and expense, any non-conforming Products in accordance with the written
instructions provided by Supplier to Customer. 

  
 10 

 4.5 Failure to Purchase Minimum Quantities. After the end of each applicable period
during the Term, Supplier may review the quantities of each Product Group or Product SKU, as applicable, ordered by Customer pursuant to Purchase Orders during such period. If such quantities are below the Monthly Period Product Quantity Minimum or
the applicable Binding Commitments for the applicable Product Groups or Product SKU, as applicable, Supplier may, after delivering to Customer the quantity of associated Products, invoice Customer for such shortfall, such invoice price to be
calculated as the amount equal to the Product Price multiplied by the difference between (a) the greater of the applicable Binding Commitments or Monthly Period Product Quantity Minimum for the applicable period and (b) the number of units
actually ordered pursuant to Purchase Orders for such period, in each case with respect to the applicable Product Groups and Product SKUs, as applicable. Customer shall pay such invoice within ninety (90) days of receipt, provided
that the Products are or were actually delivered and conform to the requirements of this Agreement. 
 5. MANUFACTURE  

5.1 Product Warranty. 
 (a)
Supplier represents and warrants that: 
 (i) The Products shall, as applicable, be manufactured, packaged, labeled, handled, stored,
transported, Sterilized and delivered (i) in accordance with applicable law and Section 4.3 in the quantities set forth in the applicable Purchase Order and (ii) consistent in in all material respects with the
Specifications (for the avoidance of doubt, the warranty with regards to Sterilization is only a warranty that an agreed upon process for anti-microbials has been administered to the Products, and not a warranty as to the results of any such
process); 
 (ii) The warranties set forth in this Section 5.1 shall not apply to the extent any claim arises
after delivery to Customer in accordance with Section 4.3 as a result of (a) any Product having been misused, neglected, improperly handled, altered, abused or used for any purpose other than the one for which it was
manufactured or other conditions beyond the control of Supplier or its Representatives, (b) any damage or defects caused by unauthorized repair or use of unauthorized parts or components or any other condition beyond the control of Supplier or
its Representatives, (c) any specifications or instructions provided to Supplier by Customer or any breach by Customer of its obligations under this Agreement, and (d) any damage or defect as a result of the actions or inactions of
Customer or its Representatives. 
 (b) Customer’s sole and exclusive remedy for, and Supplier’s sole obligation under the warranty
set forth in Section 5.1(a)(i) are set forth in Section 4.4(b). 

  
 11 

 THE WARRANTIES SET FORTH IN SECTION 5.1 SHALL BE IN LIEU OF ALL OTHER WARRANTIES, AND SUPPLIER HEREBY
DISCLAIMS ALL OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING WARRANTIES OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE, OR NON-INFRINGEMENT. WITHOUT LIMITING THE FOREGOING, SUPPLIER EXPRESSLY DISCLAIMS
ANY REPRESENTATIONS AND WARRANTIES REGARDING THE PERFORMANCE, SAFETY, AND EFFICACY OF THE PRODUCTS, WHETHER ALONE OR IN COMBINATION WITH ANY OTHER PRODUCTS OR COMPONENT(S). CUSTOMER HEREBY ACCEPTS SUCH DISCLAIMERS. 

5.2 Product Issues. Supplier will promptly, and in any case no later than five (5) Business Days, notify Customer of any lot
failure, manufacturing problems or similar issues that may impact Customer’s ability to distribute Products to its customers. 
 5.3
Reliance on Customer Instructions and Performance. In performing its obligations under this Agreement, Supplier will be entitled to rely upon any written instructions or written authorizations provided to Supplier by Customer’s
Representatives. Supplier will be relieved of its obligation to perform any obligation under this Agreement to the extent it is prevented from performing such obligation by (a) its compliance with such written instructions or
(b) Customer’s failure to perform its obligations under this Agreement. 
 5.4 Product Combination Disclaimer. Supplier
expressly disclaims any representations or warranties regarding the performance, safety and efficacy of the Product to the extent such Product is combined with any drug or compound produced by a third party, and Customer acknowledges and agrees to
such disclaimer. Supplier shall not be liable to Customer for any damages claimed by any Person due to the use of any Product to the extent such damages resulted from any compound or drug manufactured, produced or otherwise supplied by any third
party, unless any such damages are a result of the gross negligence or willful misconduct of Supplier. 
 6. PROCUREMENT OF RAW MATERIALS 

6.1 Management of Raw Materials. Supplier shall be responsible for procuring Raw Materials, except where otherwise set forth in the
Statement of Work. 
 6.2 Changes. Supplier will promptly notify Customer upon receiving any communication from a supplier with
respect to material limitations on production capacity or inventory, or any notice of discontinuation of production of, any Raw Materials that is reasonably likely to have a material impact on the manufacture and supply of Products for Customer.

 7. [FIXED ASSETS 
 7.1
Ownership of Fixed Assets. The Parties acknowledge that the Fixed Assets are owned by Customer, but shall be located in the Supplier Facility and used by Supplier to manufacture the Products hereunder throughout the Term. Supplier will use
reasonable care in operating and maintaining the Fixed Assets in an acceptable state of repair and operating efficiency so as to meet the Specifications, and Supplier shall pay for all
out-of-pocket costs incurred to perform routine repairs, replacement or maintenance of the Fixed Assets to the extent required as a result of Supplier’s gross
negligence or willful misconduct. 

  
 12 

 7.2 Maintenance. Consistent with past practices for the twelve (12) month period
immediately prior to the Effective Date, Supplier shall use commercially reasonable efforts to conduct regularly scheduled routine maintenance of the Fixed Assets. By no later than April 1 of each year, commencing April 1, 2023, Supplier
shall make available to Customer, upon Customer’s thirty (30) days’ advance written request a condition report and schedule of budgeted costs of maintenance on such Fixed Assets along with a reasonably detailed maintenance log of any
maintenance performed during the prior year. Supplier shall use commercially reasonable efforts to maintain reasonably appropriate insurance coverage with respect to the Fixed Assets. Customer shall be responsible for all costs and expenses related
to maintenance and replacement of the Fixed Assets (including the non-routine maintenance and replacement of Fixed Assets), except as set forth herein. 

7.3 New Equipment. Supplier may recommend whether and when Customer should purchase new equipment or machinery, including molds, molding
presses, packaging, and ancillary equipment relating to the Products, and whether to replace existing equipment or machinery, in each case to the extent reasonably necessary to continue the manufacture of Products under this Agreement. Customer
shall be solely responsible for approving, ordering, purchasing and insuring any such equipment or machinery (and the delivery, installation and similar expenses related thereto). Any such equipment or machinery shall be ordered, purchased, and
owned by Customer. Notwithstanding the foregoing, Customer shall not order, have delivered or install any equipment in Supplier’s Facility without Supplier’s prior written consent. Notwithstanding any provision of this Agreement to the
contrary, and without limiting the foregoing, Supplier shall have no obligation to manufacture, sell or supply Products (whether at all or in such quantities as Customer submits in Purchase Orders) or to make deliveries to Customer hereunder to the
extent Customer fails to purchase, or delays in purchasing, equipment or machinery in accordance with this Section 7.3. 

7.4 Relocation. No less than ninety days before the anticipated expiration or termination of the Term, the Parties will cooperate in
good faith to develop a plan to manage the relocation of the Fixed Assets to Customer’s possession and the transition of production of the applicable Products from Supplier to Customer or Customer’s designated Representative (such plan,
the “Implementation Plan”) after such expiration or termination. During the Term, the Fixed Assets shall remain at the applicable Facility. In all cases, the Parties commit to work together cooperatively and in good faith to
minimize any disruption to or interference with Supplier’s business, including minimizing the total time required for such relocation and transition. Customer shall pay for all relocation, disassembly, rigging, packing, shipping and similar
charges for disassembly, removal, transportation, and installation of the Fixed Assets, along with charges for any pre-approved labor charges provided by Supplier in support of the disassembly or removal of
such Fixed Assets. Notwithstanding the foregoing, Supplier shall manufacture each Product supplied under this Agreement at the Facility and manufacturing of Products may not be relocated except as otherwise provided herein or consented to in writing
by each Party. 
 7.5 Facilities; Access. Following the expiration of the Term, Supplier shall reasonably cooperate with Customer, at
Customer’s sole cost and expense, to transfer and deliver any documents, correspondence or other data to effect the transfer of any manufacturing process knowledge (excluding, for the avoidance of doubt, any intellectual property, which shall
be transferred (if at all) in accordance with the terms of the Separation and Distribution Agreement 

  
 13 

 
and the Ancillary Agreements) with respect to the Products supplied by Supplier to Customer. In connection therewith, Supplier shall permit one or more employees of Customer with reasonable
access to the Facility to observe the manufacture of Products at such times and for such periods as the Parties mutually agree, acting reasonably and in good faith. Prior to being granted access to the Facility, such employees of Customer shall
execute a confidentiality agreement in a form that is reasonably acceptable to Supplier. 
 7.6 Property Taxes. Customer shall timely
file any and all personal property tax returns with respect to the Fixed Assets that are due after the Effective Date, and shall timely pay to the appropriate tax authorities any and all personal property taxes with respect to such Fixed Assets that
are due after the Effective Date.]1 
 8. LABELING; DESIGN HISTORY FILES  

8.1 Labels and Packaging. Supplier shall label and package the Products prior to delivery using such artwork, packaging and labeling as
used by Supplier in the manufacture and packaging of the Products as of the date immediately prior to the Effective Date or as otherwise provided in the Statement of Work; provided that, if requested in writing by Customer, Supplier shall use
commercially reasonable efforts to apply barcodes to any packaging for Product (i.e., any individual packaging and/or exterior cartons pursuant to applicable law) at Customer’s expense. In the event of any requested or required artwork,
packaging, or labeling modifications pursuant to this Section 8.1 (“Labeling Modifications”), Customer shall reimburse Supplier for any costs and expenses incurred by Supplier in connection with such
development or implementation, and to the extent that any such artwork, packaging or labeling change increases Supplier’s cumulative cost of manufacturing, assembly, packaging, labeling, Sterilization (if applicable) or delivery of any Product,
the Product Price for such Product shall be increased to reflect such cumulative cost increases. Any Labeling Modifications, including the costs noted immediately above, shall be agreed by Supplier and Customer in good faith before such Labeling
Modifications are to be implemented. 
 9. REGULATORY; CUSTOMERS 

9.1 Recall. Customer shall control any recall, withdrawal, adverse event or field correction (each, a “Field Action”)
with respect to any Product. In connection with a Field Action, Supplier shall reasonably cooperate with responding to Customer’s requests for information or other assistance, and in otherwise effecting such Field Action. To the extent
reasonably possible, Customer shall consult with Supplier before issuing any press release or otherwise making any public statement or making any other public (or non-confidential) disclosure (whether or not
in response to an inquiry) regarding any Field Action that directly or indirectly references or implicates Supplier. Customer shall be responsible for communicating with any Governmental Authorities in connection with a Field Action. Customer shall
bear any costs and expenses incurred by it and by Supplier in connection with any such Field Action (including with respect to any Field Action caused by any supplier of Raw Materials); provided, however, that if a Field Action results
primarily from Supplier’s breach of its warranties under Section 5.1, Supplier shall 
  

	1 	 To be included for the Dun Laoghaire, Suzhou 3 and Drogheda CMAs/rCMAs.

  
 14 

 
pay the reasonable out-of-pocket costs incurred by Customer for each such Field Action in connection with
Customer’s response to any such Field Action, including the cost of shipping, inspecting and sorting Products impacted by such Field Action, which reimbursable costs with respect to any such Field Action shall not, in the aggregate, exceed
$1,000,000. The remedies set forth in Section 4.4(b) shall be available to Customer for (a) Products that do not conform with the warranties set forth in Section 5.1 and (b) conforming
Products that Customer is required to include in a Field Action involving non-conforming Products pursuant to applicable law. Notwithstanding anything to the contrary in this Agreement, the foregoing shall be
Customer’s sole and exclusive remedy with respect to a Field Action. Any information of any nature obtained by either Party during any Field Action shall be subject to the provisions of Section 11. 

9.2 Compliance with Laws. Supplier shall comply with applicable law with respect to the manufacture of the Products, including cGMP to
the extent applicable to the Products, and shall not be required to perform or omit to perform any act required or permitted under this Agreement if such performance or omission would violate the provisions of any such law. 

9.3 Safety Laws. Customer hereby acknowledges and agrees that many jurisdictions, including the United States, have in effect laws,
rules and/or regulations, including the Needlestick Prevention Act in the United States (the “Safety Laws”) mandating or recommending the use of protection technologies in connection with drug delivery devices and containers
(collectively, the “Safety Products”). Customer has been and will be solely responsible for making its own analysis of such Safety Products and compliance with such Safety Laws. 

9.4 Regulatory Approvals. Subject to the terms of that certain Logistics Services Agreement and that certain Transition Services
Agreement, each of even date herewith and by and between the Parties, Supplier shall not be responsible for procuring, maintaining or otherwise handling Regulatory Approvals necessary to manufacture, market and sell the Products, including the
completion of any and all international registration documentation. Supplier shall continue to maintain the Regulatory Approvals necessary to manufacture the Products at the Facility. 

9.5 Government Inspection; Requests for Information. Supplier shall, pursuant to applicable law, allow the FDA or any other Governmental
Authority with jurisdiction over Supplier’s manufacture or Customer’s marketing and distribution of Product to inspect all areas of the Facility (and, to the extent that Supplier is contractually permitted to allow such access, third-party
facilities) utilized by Supplier in the manufacture, testing, packaging, Sterilization, storage and shipment of Products sold under this Agreement, and will reasonably cooperate with such Governmental Authorities. Supplier will notify Customer as
soon as is reasonably practicable after it receives notice of an inspection if it relates to any Product. In the event of any such inspection by the FDA or other Governmental Authority (including an inspection by an agency or organization appointed
by the FDA or other Governmental Authority), Supplier shall contact Customer to inform Customer of such inspection and of any material non-conformity which may impact the fit, form or function or the
regulatory status (510(k) or otherwise) of any of the Products supplied to Customer. 

  
 15 

 9.6 Complaints; Communications. Customer shall be responsible for handling and
addressing all Complaints and customer communications (including general inquiries) concerning any Product. In the event Supplier receives or becomes aware of a Complaint or communication about any Product, Supplier shall promptly notify Customer
and refer such Complaint or communication, and any relevant information or documentation obtained with respect thereto, to Customer. Customer shall be responsible for communicating with customers regarding any Complaint about any Product, unless
otherwise agreed upon by both Parties during a specific complaint investigation. Each Party shall provide the other Party with the telephone numbers and names of contacts for this purpose. Customer shall be responsible for investigating any
Complaint about the Products, making filing determinations with respect to any Complaint, reporting any Complaints to the applicable Governmental Authority, including, for the avoidance of doubt, filing medical device reports and ex-US vigilance reports, implementing any corrective action where necessary, and responding directly to the customer about its complaint, and Customer shall bear all costs associated therewith. Supplier shall
cooperate with Customer in connection with any complaint investigation and promptly respond to Customer’s requests for information or provide such other assistance as Customer may reasonably request, at Customer’s expense. 

10. INDEMNIFICATION 
 10.1
Supplier Indemnification. Subject to the provisions of Section 10.3, Supplier shall defend, indemnify and hold harmless Customer and its Representatives and their permitted successors and assigns with respect to any
liability, damage, loss or expenses (including reasonable attorneys’ fees and court costs) relating to third party claims (collectively, “Losses”) arising out of, relating to, or resulting from: (a) any breach or default
by Supplier of any representation, warranty or covenant of Supplier contained in this Agreement, but not including the express warranties provided in Section 5.1(a)(i) (the remedies for which are expressly limited to those
set forth in Section 4.4(b), except in the case of fraud, gross negligence or willful misconduct on the part of Supplier); (b) Supplier’s failure to comply with the express warranties provided in
Section 5.1(a)(i) and (ii), solely to the extent the subject of a third party claim for personal injury or death; (c) the fraud, gross negligence or willful misconduct of Supplier in the course of the performance of
its obligations hereunder; or (d) claims that Supplier’s conduct of any New Manufacturing Process infringes, misappropriates, or violates any intellectual property rights of third parties. 

10.2 Customer Indemnification. Subject to the provisions of Section 10.3, Customer shall defend, indemnify and
hold harmless Supplier and its Representatives and their permitted successors and assigns with respect to all Losses arising out of, relating to, or resulting from: (a) any breach or default by Customer of any representation, warranty or
covenant of Customer contained in this Agreement; (b) the gross negligence, willful misconduct or fraud of Customer in connection with this Agreement; (c) the use, sale, import, export or exploitation of the Products, except for such
indemnification obligations of the Supplier under Section 10.1 or (d) any needlestick injury or similar damage sustained or alleged by any Person involved in the handling, shipping, manufacture, assembly, sale,
distribution, supply, use or operation of any Product on or after delivery of such Product. 

  
 16 

 10.3 Procedure. Promptly after receipt of written notice of the assertion or the
commencement of a third party claim asserted against a Party for which the other Party has an indemnification obligation under this Section 10, the indemnified Party shall provide the indemnifying Party with written notice
describing an indemnification claim (“Claim”) in reasonable detail in light of the circumstances then known and then providing the indemnifying Party with further notices to keep it reasonably informed with respect thereto;
provided, however, that failure of the indemnified Party to provide timely notice or to keep the indemnifying Party reasonably informed as provided herein shall not relieve the indemnifying Party of its obligations hereunder except
to the extent that the indemnified Party is materially prejudiced thereby. If any proceeding shall be commenced against any indemnified Party by a third party, the indemnifying Party shall be entitled to participate in such Claim and assume the
defense thereof with counsel reasonably satisfactory to the indemnified Party, at the indemnifying Party’s sole cost and expense, and the indemnifying Party shall reasonably cooperate with the indemnifying Party, at the indemnifying
Party’s sole cost and expense, in the defense of any Claim and shall be entitled to participate in any proceeding at its expense, and the indemnifying Party shall not settle such proceeding without the indemnified Party’s prior written
consent (which consent shall not be unreasonably withheld or delayed), except such consent shall not be required in the case of any settlement that includes a full and unconditional release of the indemnified Party by the plaintiff or claimant from
all liability with respect to the matters that are subject to such Claim. The indemnified Party may participate in the defense of any claim with counsel reasonably acceptable to the indemnifying Party, at the indemnified Party’s own expense.

 10.4 Limitation of Liability. For the avoidance of doubt, the terms of this Section 10.4 do not apply to
claims arising out of the Separation and Distribution Agreement or any other Ancillary Agreement (as defined in the Separation and Distribution Agreement). 

(a) EXCEPT FOR (I) CLAIMS PURSUANT TO A BREACH OF THE CONFIDENTIALITY OBLIGATIONS SET FORTH IN SECTION 11, (II) THIRD PARTY CLAIMS
FOR WHICH A PARTY HAS AN INDEMNIFICATION OBLIGATION UNDER SECTION 10.1(b) OR SECTION 10.2(b) and (c) AND (III) CUSTOMER’S PAYMENT OBLIGATIONS UNDER SECTION 3, TO THE MAXIMUM EXTENT PERMITTED BY APPLICABLE LAW,
NEITHER PARTY WILL BE LIABLE TO THE OTHER FOR ANY LOST PROFITS, LOSS OF DATA, LOSS OF USE, BUSINESS INTERRUPTION OR OTHER SPECIAL, INCIDENTAL, INDIRECT, PUNITIVE, EXEMPLARY, OR CONSEQUENTIAL DAMAGES, HOWEVER CAUSED, UNDER ANY THEORY OF LIABILITY,
ARISING FROM THE PERFORMANCE OF, OR RELATING TO, THIS AGREEMENT REGARDLESS OF WHETHER SUCH PARTY HAS BEEN NOTIFIED OF THE POSSIBILITY OF, OR THE FORESEEABILITY OF, SUCH DAMAGES. 

(b) IN ADDITION, SUPPLIER SHALL NOT BE LIABLE FOR ANY DAMAGES ARISING FROM CLAIMS OF THIRD PARTIES FOR PERSONAL INJURY OR DEATH TO THE EXTENT A
RESULT OF THE USE OF ANY PRODUCT, OR FAILURE OF SUPPLIER TO WARN, OR TO ADEQUATELY WARN, AGAINST THE DANGERS OF THE PRODUCTS OR FAILURE OF SUPPLIER TO INSTRUCT, OR TO ADEQUATELY INSTRUCT, ABOUT THE SAFE AND PROPER USE OF THE PRODUCTS, EXCEPT AS
CONTEMPLATED BY SECTION 10.1(b) or (c). NOTWITHSTANDING ANYTHING ELSE TO THE CONTRARY SET FORTH IN THIS AGREEMENT OR THE SEPARATION AND DISTRIBUTION AGREEMENT, EXCEPT FOR (I) CLAIMS PURSUANT TO A BREACH OF THE
CONFIDENTIALITY OBLIGATIONS SET FORTH IN SECTION 11, (II) THIRD PARTY CLAIMS FOR WHICH A PARTY HAS AN INDEMNIFICATION OBLIGATION UNDER SECTION 10.1(b), OR SECTION 10.2, (III) CUSTOMER’S PAYMENT

  
 17 

 
OBLIGATIONS UNDER THIS AGREEMENT, AND (IV) FRAUD, GROSS NEGLIGENCE OR WILLFUL MISCONDUCT BY EITHER PARTY, AND, THE MAXIMUM LIABILITY OF A PARTY UNDER THIS AGREEMENT FOR ALL CLAIMS UNDER ANY
THEORY OF LIABILITY SHALL NOT EXCEED THE GREATER OF (X) ONE MILLION U.S. DOLLARS ($1,000,000) OR (Y) TEN PERCENT (10%) OF THE AGGREGATE SUM OF PAYMENTS MADE BY CUSTOMER TO SUPPLIER PURSUANT TO SECTION 3.1 OF THIS AGREEMENT DURING THE TERM.
CUSTOMER FURTHER ACKNOWLEDGES THAT ANY RIGHT OF RECOVERY (BY SUBROGATION OR OTHERWISE) BY CUSTOMER’S INSURER IS HEREBY WAIVED AND CUSTOMER’S INSURER SHALL NOT HAVE ANY OTHER RECOURSE AGAINST SUPPLIER FOR DAMAGES PAID UNDER CUSTOMER’S
INSURANCE POLICIES FOR LIABILITIES ARISING IN CONNECTION WITH THIS AGREEMENT. 
 11. CONFIDENTIAL INFORMATION 

11.1 BD and SpinCo Obligations. Subject to Section 11.4, until the six (6)-year anniversary of the date of the
termination of this Agreement in its entirety, each of BD and SpinCo, on behalf of itself and each of its Subsidiaries, agrees to hold, and to cause its respective Representatives to hold, in strict confidence, with at least the same degree of care
that applies to BD’s confidential and proprietary information pursuant to policies in effect as of the Effective Time, all confidential and proprietary information concerning the other Party or its Subsidiaries or their respective businesses
that is either in its possession (including confidential and proprietary information in its possession prior to the date hereof) or furnished by such other Party or such other Party’s Subsidiaries or their respective Representatives at any time
pursuant to this Agreement, and shall not use any such confidential and proprietary information other than for such purposes as may be expressly permitted hereunder, except, in each case, to the extent that such confidential and proprietary
information (a) is in the public domain or is generally available to the public, other than as a result of a disclosure by such Party or any of its Subsidiaries or any of their respective Representatives in violation of this Agreement;
(b) is lawfully acquired from other sources by such Party or any of its Subsidiaries, which sources are not themselves known by such Party or any of its Subsidiaries to be bound by a confidentiality obligation or other contractual, legal or
fiduciary obligation of confidentiality with respect to such confidential and proprietary information; (c) is independently developed or generated without reference to or use of the confidential and proprietary information of the other Party or
any of its Subsidiaries; or (d) was in such Party’s or its Subsidiaries’ possession on a non-confidential basis prior to the time of disclosure to such Party and at the time of such disclosure
was not known by such Party or any of its Subsidiaries to be prohibited from being disclosed by a confidentiality obligation or other contractual, legal or fiduciary obligation of confidentiality with respect to such confidential and proprietary
information. If any confidential and proprietary information of a Party or any of its Subsidiaries is disclosed to the other Party or any of its Subsidiaries in connection with Supplier’s supply of the Products and provision of related services
and manufacturing activities hereunder, then such disclosed confidential and proprietary information shall be used only as required for Supplier’s supply of the Products and provision of related services and manufacturing activities. 

11.2 No Release; Return or Destruction. Each Party agrees (a) not to release or disclose, or permit to be released or disclosed,
any Confidential Information of the other Party addressed in Section 11.1 to any other Person, except its Representatives who need to know such confidential and proprietary information in their capacities as such (who shall
be advised of their obligations hereunder with respect to such confidential and proprietary 

  
 18 

 
information) and except in compliance with Section 11.4, and (b) to use commercially reasonable efforts to maintain such confidential and proprietary information in
accordance with Section 6.4 of the Separation and Distribution Agreement. Without limiting the foregoing, when any such confidential and proprietary information is no longer needed for the purposes contemplated by this Agreement, each Party
will promptly after request of the other Party either return to the other Party all such confidential and proprietary information in a tangible form (including all copies thereof and all notes, extracts or summaries based thereon) or notify the
other Party in writing that it has destroyed such information (and such copies thereof and such notes, extracts or summaries based thereon); provided that the Parties may retain electronic back-up
versions of such confidential and proprietary information maintained on routine computer system backup tapes, disks or other backup storage devices; and provided, further, that any such retained back-up
information shall remain subject to the confidentiality provisions of this Agreement. 
 11.3 Privacy and Data Protection Laws. Each
Party shall comply with all applicable state, federal and foreign privacy and data protection laws that are or that may in the future be applicable to the supply of the Products and provision of related services and manufacturing activities under
this Agreement. 
 11.4 Injunctive Relief. In the event that a Party or any of its Subsidiaries either determines on the advice of its
counsel that it is required to disclose any information pursuant to applicable law or receives any request or demand under lawful process or from any Governmental Authority to disclose or provide information of the other Party (or any of its
Subsidiaries) that is subject to the confidentiality provisions hereof, such Party shall notify the other Party (to the extent legally permitted) as promptly as practicable under the circumstances prior to disclosing or providing such information
and shall cooperate, at the expense of the other Party, in seeking any appropriate protective order requested by the other Party. In the event that such other Party fails to receive such appropriate protective order in a timely manner and the Party
receiving the request or demand reasonably determines that its failure to disclose or provide such information shall actually prejudice the Party receiving the request or demand, then the Party that received such request or demand may thereafter
disclose or provide information to the extent required by such law (as so advised by its counsel) or by lawful process or such Governmental Authority and will exercise reasonable efforts to obtain assurance that confidential treatment will be
accorded to such confidential and proprietary information, and the disclosing Party shall promptly provide the other Party with a copy of the information so disclosed, in the same form and format so disclosed, together with a list of all Persons to
whom such information was disclosed, in each case to the extent legally permitted. 
 11.5 Injunctive Relief. It is understood and
agreed that money damages may not be a sufficient remedy for any breach of this Section 11, and that the disclosing Party may be entitled to specific performance and injunctive or other equitable relief as a remedy for any
such breach. Such remedy shall not be deemed to be the exclusive remedy for breach of this Section 11, but shall be in addition to all other remedies available at law or equity to the disclosing Party. 

  
 19 

 11.6 Survival. Subject to Section 11.4, the obligations in
this Section 11 shall survive any expiration or termination of this Agreement for six (6) years after the date of expiration or termination of this Agreement; provided, however, that, with respect to each
trade secret of a Party, such obligations shall continue as long as such trade secret remains otherwise protectable as a trade secret. In the event of a conflict, contradiction, or inconsistency between any other agreement executed by the Parties or
their Representatives at the Closing concerning rights to trade secrets at the Facility, such other agreement shall govern and prevail over the language in the preceding sentence. 

12. RECORDS; INSPECTION; ACCESS TO FACILITIES 

12.1 Manufacturing Records. Supplier agrees to retain all applicable records relating to the manufacturing of Products for a period of
not less than seven (7) years from the date of delivery of Product, or such longer period as may be required by applicable law. Supplier shall provide Customer with complete and accurate copies of such records, upon Customer’s request and
at Customer’s expense. 
 12.2 Inspection. Subject to Supplier’s consent (not to be unreasonably withheld), on an annual
basis, or more frequently with reasonable cause, Supplier agrees to permit Customer, Customer’s contract manufacturers acting on Customer’s behalf and any Representatives to enter and inspect, upon at least fifteen (15) days’
prior written notice and during normal business hours, the Facility that is used to manufacture, label, package, Sterilize and store the Products to determine whether Supplier’s manufacturing processing, labeling, packaging, Sterilization or
storage of the Products conform with the applicable Specifications and otherwise comply with the requirements of this Agreement and applicable law; provided any such inspection does not unreasonably interfere with Supplier’s continued
operation of its business and Customer executes (and causes its applicable Representatives to execute pursuant to Section 12.3) a confidentiality agreement as a condition to being provided access to the Facility. The
foregoing notice obligation shall be diminished to one (1) business day if the inspection is necessitated by a good faith concern related to Product quality or compliance with applicable laws where such shortened notice period may serve to
mitigate immediate harm or damage to Customer or its end-users. 
 12.3 Access by Customer
Personnel. Prior to allowing any of its Representatives to enter into the Facility, Customer shall require such Representatives to enter into confidentiality agreements with Supplier that contains provisions that are consistent with the
provisions of Section 11. Customer shall cause all of its Representatives to comply with all reasonable Supplier instructions and policies while at the Facility, and Supplier shall have the right to remove any
Representatives of Customer from the Facility for failure to comply with such instructions or policies. 
 13. TERM AND TERMINATION; TRANSITION OF
PRODUCTION 
 13.1 Term. The term of this Agreement (the “Term”) shall be as set forth in the Statement of
Work. 
 13.2 Termination on Account of Material Breach. Either Party may terminate this Agreement, in whole or in part, without
liability, except for amounts due and payable hereunder as of the date of termination, in the event the other Party breaches any material provision of this Agreement and fails to cure such breach, if capable of being cured, within ninety
(90) days after receipt of written notice (which notice shall specify in reasonable detail the nature of such breach). This right shall be in addition to any other remedies provided by law. 

  
 20 

 13.3 Termination on Account of Bankruptcy. This Agreement may be terminated
immediately upon written notice by one Party to the other if the other Party becomes insolvent, makes an assignment for the benefit of creditors, has a receiver appointed for it or any of its assets, or files or has filed against it a petition,
under the Bankruptcy Code of 1978, as amended, 11 U.S.C. § 101 et seq. (or bankruptcy law of another country), or under any insolvency laws providing for the relief of debtors, where such petition, assignment or similar proceeding
is not dismissed within ninety (90) days following its filing. 
 13.4 Customer’s Right to Termination. Customer may
terminate this Agreement during the Term in whole or with respect only to certain Products, including on a SKU by SKU basis, at any time without cause upon one-hundred-twenty (120) days’ prior
written notice to Supplier; provided that, in connection with any such termination by convenience, Customer shall reimburse Supplier for any amounts due and payable hereunder as of the date of termination (including any costs and expenses
reasonably incurred by Supplier in anticipation of this Agreement continuing for the duration of the Term). 
 13.5 Termination on Account
of Change of Control. In the event that SpinCo consummates a Change of Control, then BD will have the right to terminate this Agreement in response to the consummation of the Change of Control by SpinCo, which right may be exercised by BD in its
sole discretion. Such termination right will be exercisable once the notice to BD of the consummation of the Change of Control has been provided (which notice shall be provided promptly). 

13.6 Raw Materials; Work in Progress; Inventory. 

(a) Upon expiration of the Term or any termination pursuant to this Agreement, the Parties shall discuss in good faith (i) Customer
purchasing from Supplier all Raw Materials that remain in Supplier’s inventory as of the effective date of such expiration or termination to the extent such Raw Materials relate specifically to the Products and were acquired by Supplier for and
specifically allocated by Supplier to the manufacture of the Products, and (ii) Customer assuming all third party purchase commitments or open purchase orders for Raw Materials or services attributable to the Products to the extent such
purchase commitments cannot be cancelled without penalty, surcharge, default or other adverse consequence to Supplier, provided, however, that such commitments are consistent with the Rolling Forecast. Notwithstanding anything to the
contrary in this Agreement, if, prior to expiration or termination of this Agreement, Supplier has ordered Raw Materials for the supply of replacement Products pursuant to Section 4.4 or has commenced the manufacture of
replacement Products pursuant to Section 4.4, Supplier shall complete the supply of such replacement Products and Customer shall not have the right to seek a refund for the rejected Products to be replaced with such
replacement Products. 
 (b) In addition to the foregoing, Customer shall remain obligated to purchase from Supplier all quantities of
Products reflected in any Purchase Orders, the Binding Commitment, and, to the extent applicable, the binding portion of the Semi-Binding Commitment of the Rolling Forecast in effect as of the effective date of termination. 

  
 21 

 (c) Any Raw Materials and works in progress purchased by Customer under this Agreement
(including as set forth in Sections 13.6(a)-(b)) shall be at Supplier’s sole cost, and any finished Product and open Purchase Order obligations shall be purchased at the Product Prices. Customer shall only be obligated to purchase Raw
Materials that comply with the Specifications for such Raw Materials. Any Raw Materials that do not comply with the Specifications at the time of delivery to Customer may be returned to Supplier at Supplier’s sole cost. 

13.7 Transport of Fixed Assets. [Upon expiration or termination of this Agreement, or at such other time as the Parties may mutually
agree pursuant to Section 7.4, Supplier shall disconnect the Fixed Assets from utilities and mechanical and electronic systems and shall be responsible for moving the Fixed Assets to appropriate loading facilities at the
Supplier Facility as necessary for Customer or its Representatives to have access to the Fixed Assets. Customer shall dismantle and crate for transportation and transport the Fixed Assets to Customer’s facilities (or Customer’s designated
third party’s facilities) at its own expense. The removal of the Fixed Assets and inventories shall be completed as soon as possible, but in no event later than ninety (90) days following termination or expiration of this Agreement, under
Supplier’s supervision and at such times as may be mutually agreed by the Parties.]2 

13.8 Survival. Section 1, Section 4.4(b), Section 5,
Section 7.1, Section 7.2, Section 7.4, Section 7.5, Section 7.6, Section 9,
Section 10, Section 11, Section 12.1, Section 13.6, Section 13.7 and this Section 13.8, and
Section 14 shall survive the expiration or termination of this Agreement in each case in accordance with their respective terms. In no event shall Supplier’s obligation to supply Products under this Agreement extend
beyond the Term. 
 14. MISCELLANEOUS 

14.1 Successors; Assigns. The succession and assignment provisions set forth in Section 10.3 of the Separation and
Distribution Agreement shall apply to this Agreement mutatis mutandis. Notwithstanding anything in this Section 14.1 to the contrary, no assignment shall relieve the assigning Party of its obligations hereunder. 

14.2 Relationship of the Parties. In performing their respective obligations hereunder, each of the Parties will operate as, and have
the status of, an independent contractor and will not act as or be an agent, partner, co-venturer or employee of the other Party. Neither Party shall represent itself to be, or otherwise conduct itself as, an
agent of the other Party and nothing contained in this Agreement shall be construed to give either Party the power to direct or control the day-to-day activities of the
other or create or assume any obligation on behalf of the other. This Agreement does not create a partnership or joint venture between the Parties. 

14.3 Governing Law. The rights and obligations of the Parties shall be governed by, and this Agreement shall be interpreted, construed
and enforced in accordance with, the laws of the State of Delaware, excluding its conflict of laws rules to the extent such rules would apply the law of another jurisdiction. 
  

 
  

	2 	 To be included if Section 7 is included. 

  
 22 

 14.4 Jurisdiction; Waiver of Jury Trial. 

(a) Each of the Parties hereby irrevocably and unconditionally submits to the exclusive jurisdiction of the Court of Chancery of the State of
Delaware or, the United States District Court for the District of Delaware, and any appellate court from any appeal thereof, in any action arising out of or relating to this Agreement or the transactions contemplated hereby, and each of the Parties
hereby irrevocably and unconditionally (i) agrees not to commence any such action except in such courts, (ii) agrees that any claim in respect of any such action may be heard and determined in the Court of Chancery of the State of Delaware
or, to the extent permitted by law, in such other courts, (iii) waives, to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any such action in the Court of
Chancery of the State of Delaware or such other courts, (iv) waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action in the Court of Chancery of the State of Delaware or such other
courts and (v) consents to service of process in the manner provided for notices in Section 14.7. Nothing in this Agreement will affect the right of any Party to serve process in any other manner permitted by law. 

(b) EACH OF THE PARTIES HEREBY IRREVOCABLY WAIVES ITS RIGHT TO A JURY TRIAL IN CONNECTION WITH ANY ACTION, PROCEEDING OR CLAIM ARISING OUT OF
OR RELATING TO THIS AGREEMENT OR ANY TRANSACTION CONTEMPLATED HEREBY. 
 14.5 Entire Agreement. This Agreement, including the other
documents, exhibits, schedules and agreements specifically referred to herein, constitutes the entire agreement between and among the Parties hereto with regard to the subject matter hereof, and supersedes all prior agreements and understandings
with regard to such subject matter. There are now no agreements, representations or warranties between or among the Parties other than those set forth in the Separation and Distribution Agreement or the documents and agreements contemplated in the
Separation and Distribution Agreement or this Agreement. 
 14.6 Amendment, Waivers and Consents. This Agreement shall not be changed
or modified, in whole or in part, except by supplemental agreement or amendment signed by the Parties. Any Party may waive compliance by any other Party with any of the covenants or conditions of this Agreement, but no waiver shall be binding unless
executed in writing by the Party making the waiver. No waiver of any provision of this Agreement shall be deemed, or shall constitute, a waiver of any other provision, whether or not similar, nor shall any waiver constitute a continuing waiver. Any
consent under this Agreement shall be in writing and shall be effective only to the extent specifically set forth in such writing. 
 14.7
Notices. Any notice required or permitted to be given hereunder shall be sufficient if in writing and (a) delivered in person or by express delivery or courier service or (b) deposited in the mail registered or certified first class,
postage prepaid and return receipt requested (provided that any notice given pursuant to clause or (c) is also confirmed by the means described in clause (a) or (b)) to such address or facsimile of the Party set forth below or to such
other place or places as such Party from time to time may designate in writing in compliance with the terms hereof. Each notice shall be deemed given when so delivered personally, or, if sent by express delivery or courier service one
(1) Business Day after being sent, or if mailed, five (5) Business Days after the date of deposit in the mail. A notice of change of address shall be effective only when done in accordance with this Section 14.7.

  
 23 

 To BD at: Becton, Dickinson and Company 

1 Becton Drive 
 Franklin Lakes,
New Jersey 07417 
 Attention: Joseph LaSala 

Chief Counsel - Transactions/M&A 

E-mail:     joseph_lasala@bd.com 

To SpinCo at:  Embecta Corp. 

300 Kimball Drive 
 Parsippany,
New Jersey 07054 
 Attention: Jeff Mann 

Senior Vice President, General Counsel, 

Head of Corporate Development and Corporate Secretary 

E-mail:     jeff.mann@bd.com; jeff.mann@embecta.com 

14.8 Force Majeure Events. 

(a) Neither Supplier nor Customer shall be liable for loss, damage, detention, delay or failure to perform resulting from any cause whatsoever
beyond its reasonable control or resulting from a force majeure (“Force Majeure Event”), including earthquake, fire, flood, infectious diseases, public health developments, epidemics and pandemics (including, for the avoidance of
doubt, COVID-19 (and any evolutions or mutations thereof) and the effects of any quarantine restrictions or other measures taken by a Governmental Authority or any other person in response thereto), strike or
lockout (other than a strike or lockout involving Supplier’s own employees), actions of a civil or military authority, insurrection, war, embargo, an act of terrorism and container or transportation shortage. Delivery dates for Product shall be
extended to the extent of any delays resulting from the foregoing or similar causes. The Party so affected shall give prompt notice to the other Party of such cause, and shall take whatever reasonable steps are necessary to relieve the effect of
such cause as rapidly as reasonably possible. Notwithstanding the foregoing, nothing in this Section 14.8 shall relieve Customer of its obligation to pay for Product received from Supplier and accepted by Customer pursuant
to this Agreement. 
 (b) In addition to and not in lieu of the terms and conditions above, if a Force Majeure event causes a shortage of Raw
Materials or a shortage of Product, Supplier shall equitably allocate such Raw Materials or Product among all of Supplier’s requirements with respect to such Raw Materials or Products, based on, where applicable, both parties’ usage for
the twelve (12)-month period prior to such Force Majeure event. 
 14.9 Interpretation. Except as otherwise explicitly specified to
the contrary, (a) references to a Section, Article, Exhibit or Schedule means a Section or Article of, or Schedule or Exhibit to, this Agreement, unless another agreement is specified, (b) the word “including” (in its various
forms) means “including without limitation,” (c) references to a particular statute or regulation include all rules and regulations thereunder and any predecessor or successor statute, rules or regulation, in each case as amended or
otherwise modified from time to time, (d) words in 

  
 24 

 
the singular or plural form include the plural and singular form, respectively, (e) references to a particular person include such Person’s successors and assigns to the extent not
prohibited by this Agreement, and (f) the headings contained in this Agreement, in any Exhibit or Schedule hereto and in the table of contents to this Agreement are for reference purposes only and shall not affect in any way the meaning or
interpretation of this Agreement. 
 14.10 Rules of Construction. The Parties acknowledge that each Party has read and negotiated the
language used in this Agreement. The Parties agree that, because all Parties participated in negotiating and drafting this Agreement, no rule of construction shall apply to this Agreement which construes ambiguous language in favor of or against any
Party by reason of that Party’s role in drafting this Agreement. 
 14.11 Severability. If any provision of this Agreement, as
applied to either Party or to any circumstance, is declared by a court of competent jurisdiction to be illegal, unenforceable or void, this Agreement shall continue in full force and effect without said provision. 

14.12 Exhibits and Schedules. All Exhibits and Schedules attached hereto, including the Statement of Work, shall be deemed to be a part
of this Agreement and are fully incorporated in this Agreement by this reference. In the event of a conflict between this Agreement and the Statement of Work, the terms of the Statement of Work shall control. 

14.13 Rights of Parties. Nothing in this Agreement, whether express or implied, is intended to confer any rights or remedies under or by
reason of this Agreement on any persons other than the Parties and their respective successors and permitted assigns, nor is anything in this Agreement intended to relieve or discharge the obligation or liability of any third person to any Party,
nor shall any provision give any third person any right of subrogation or action over or against any Party. 
 14.14 Counterparts.
This Agreement may be signed in any number of counterparts, including facsimile copies thereof or electronic scan copies thereof delivered by electronic mail, each of which shall be deemed an original, with the same effect as if the signatures
thereto and hereto were upon the same instrument. 
 14.15 No Licenses. Nothing in this Agreement shall be construed as a grant by
Supplier of any right or license whatsoever to Customer under any patent, patent application or other proprietary right now or hereafter owned or controlled by the Customer except to the extent required for Supplier to perform its obligations
hereunder. 
 [The remainder of this page is intentionally left blank.] 

 

  
 25 

 IN WITNESS WHEREOF, the Parties have caused this Agreement to be executed by their duly
authorized representatives as evidenced by their signatures below. 
  

			
	BECTON, DICKINSON AND COMPANY
		
	By:	 	
                 

		 	Name: [    ]
		 	Title: [    ]
	
	EMBECTA CORP.
		
	By:	 	              

		 	Name: [    ]
		 	Title: [    ]

 [Signature Page to Contract Manufacturing Agreement]EX-10.6

 Exhibit 10.6 

EXECUTION VERSION 

 

Certain confidential information contained in this document, marked by brackets, has been omitted because it is both
(i) not material and (ii) would be competitively harmful if publicly disclosed. 

 CANNULA SUPPLY AGREEMENT 

This CANNULA SUPPLY AGREEMENT (together with the Exhibits hereto, this “Agreement”), is made and entered into as of March 31, 2022 (the
“Effective Date”), by and between BECTON, DICKINSON AND COMPANY, a corporation organized under the laws of New Jersey, with a place of business at 1 Becton Drive, Franklin Lakes, New Jersey 07417 (“Parent”), and
EMBECTA CORP., a corporation organized under the laws of Delaware, with a place of business at 1 Becton Drive, Franklin Lakes, New Jersey 07417 (“SpinCo”) (each of Parent and SpinCo individually referred to as a
“Party” and collectively referred to as the “Parties”). 
 WHEREAS, Parent is one of the leading suppliers of
cannula, which are utilized in various medical devices, including for hypodermics and pen needles for use in the diabetes care sector; 
 WHEREAS,
Parent and SpinCo entered into that certain Separation and Distribution Agreement, dated as of March 31, 2022 (the “Separation and Distribution Agreement”); and 

WHEREAS, subject to the Separation and the Distribution Agreement, Parent and SpinCo are entering into this Agreement, pursuant to
which SpinCo will purchase from Parent, and Parent will sell to SpinCo, cannulas solely for integration into certain medical devices to be produced and sold by SpinCo for use for the Permitted Purposes (as defined below). 

NOW, THEREFORE, in consideration of the mutual covenants and agreements hereinafter set forth, and for other good and valuable consideration, the
receipt and sufficiency of which are hereby acknowledged, the Parties hereto agree as follows. 
 ARTICLE 1 

DEFINITIONS 
 Each of the capitalized terms
in this Agreement (other than the section headings), whether used in singular or plural, shall have the respective meaning as set forth below or, if not listed below, the meaning as designated in other places throughout this Agreement. 

1.1 “2022 Base Forecast” means Parent’s forecast of Product SKU orders for use for the Permitted Purposes (excluding
clause (b) thereof) for the twelve (12)-month period starting on October 1, 2021 and ending on September 30, 2022, which is attached hereto as Exhibit J. 

1.2 “2022 Base Forecast Amount” means, with respect to any Product Group or Product SKU, the total units of such Product Group
or Product SKU forecast, as the case may be, to be ordered for use for the Permitted Purposes (excluding clause (b) thereof) in the 2022 Base Forecast. 

1.3 “Absorption” has the meaning set forth on Exhibit L to this Agreement. 

1.4 “Absorption Variance” has the meaning set forth on Exhibit L to this Agreement. 

1.5 “Accounting Principles” means those principles set forth on Exhibit G to this Agreement. 

 1.6 “Affiliate” has the meaning set forth in the Separation and
Distribution Agreement. 
 1.7 “Allowable Purchase Cap” means, subject to Section 6.4(d): 

(a) beginning in Year 1 and for each Fiscal Year thereafter until the Yearly Base Forecast for a Fiscal Year is at least [* * *] billion units
less than the Applicable Purchase Cap for the previous Fiscal Year: [* * *] billion units of Product, subject to increase under Section 4.7 (the “Maximum Allowable Purchase Cap”), such Allowable Purchase Cap to be apportioned
by Product Group based on the proportion of the 2022 Base Forecast Amount for the applicable Product Group to the total 2022 Base Forecast Amount for all Product Groups unless otherwise mutually agreed by the Parties pursuant to Section 4.7;
and 
 (b) beginning in the Fiscal Year in which the Yearly Base Forecast for such Year is at least [* * *] billion units less than the
Allowable Purchase Cap for the previous Fiscal Year and for each subsequent Fiscal Year during the Term: 110% of the greater of the Yearly Base Forecast from the immediately prior Fiscal Year or the Yearly Base Forecast from the year immediately
prior to such prior Fiscal Year, divided by Product Group based on the proportion of the applicable Yearly Base Forecast Amount for the applicable Product Group to the total Yearly Base Forecast Amount for the applicable Fiscal Year for all Product
Groups; provided that, with respect to this clause (b), in no Fiscal Year shall the Allowable Purchase Cap for any Product Group be higher than the Allowable Purchase Cap for such Product Group in any prior Fiscal Year (i.e., the
Allowable Purchase Cap for each Product Group may decrease but may never increase). 
 1.8 “Ancillary Agreements” has the
meaning set forth in the Separation and Distribution Agreement. 
 1.9 “Calendar Quarter” means each three (3)-Month period
starting on January 1st, April 1st, July 1st or October 1st. 
 1.10 “Cartridge” means (1) any cartridge used by Parent to
package the Products for shipment to SpinCo under this Agreement or (2) any cartridge supplied by Parent to SpinCo for use at a SpinCo facility to transfer third party-sourced cannula from the third party shipping container in accordance with
the IP Matters Agreement. 
 1.11 “Change of Control” means, with respect to a Party, (a) a merger or consolidation of such
Party with a Third Party, but only if the voting securities of such Party outstanding immediately prior thereto (or, if such voting securities are converted or exchanged in such merger or consolidation, any securities into which such voting
securities have been converted or exchanged) neither represents (x) at least fifty percent (50%) of the combined voting power of the surviving entity of such merger or consolidation nor (y) at least fifty percent (50%) of the ultimate
parent of such surviving entity immediately after such merger or consolidation, (b) a transaction or series of related transactions in which a Third Party, together with its Affiliates, becomes the beneficial owner of fifty percent (50%) or
more of the combined voting power of the outstanding securities of such Party, or (c) the sale or other transfer to a Third Party, directly or indirectly, of all or substantially all of such Party’s assets or business to which the subject
matter of this Agreement relates. 
  

	[* * *] =	 [CONFIDENTIAL PORTION HAS BEEN OMITTED BECAUSE IT (I) IS NOT MATERIAL AND (II) WOULD BE
COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. 

  

					
		  	Page 2 of 35	  	

 1.12 “Fiscal Year” means each twelve (12)-Month period between October 1st and September 30th, provided that (a) the first “Fiscal Year” of the Term will commence on the Effective Date and end on
the first occurrence of September 30th thereafter and (b) the final “Fiscal Year” of the Term will end on the termination of this Agreement. As used in this Agreement, “Year
1” shall mean the first Fiscal Year of the Term, “Year 2” shall mean the second Fiscal Year of the Term, and so forth. 

1.13 “IP Matters Agreement” has the meaning set forth in the Separation and Distribution Agreement. 

1.14 “Joint Operations Group” has the meaning set forth in Section 6.3. 

1.15 “Laws” has the meaning set forth in the Separation and Distribution Agreement.. 

1.16 “Lost Mark-up” has the meaning set forth on Exhibit L to this Agreement.

 1.17 “Major Supply Failure” means, on a Product
SKU-by-Product SKU basis, with respect to a Product SKU, a failure of Parent, for any reason, including a Force Majeure, (a) to deliver during any three
(3) successive Months during the Term of this Agreement, fifty percent (50%) of the aggregate quantity of such Product SKU ordered by SpinCo for delivery in accordance with this Agreement during such three (3)-Month period, or (b) to
deliver during any six (6) successive Months during the Term of this Agreement, seventy-five percent (75%) of the aggregate quantity of such Product SKU ordered by SpinCo for delivery in accordance with this Agreement during such six (6)-Month
period, but, in either case ((a) or (b)), notwithstanding anything to the contrary in this Agreement, excluding any such failure caused by the negligent acts or omissions of SpinCo or breach of this Agreement by SpinCo. 

1.18 “Major Supply Failure Termination Event” means, on a Product SKU-by-Product SKU basis, that either (a) Parent is unable to supply at least twenty percent (20%) of the units of the applicable Product SKU forecast to be ordered by SpinCo in its Updated Forecast in
the period that is twelve (12) months following commencement of the Major Supply Failure or (b) Parent is unable to supply one hundred percent (100%) of the units of the applicable Product SKU forecast to be ordered by SpinCo in its
Updated Forecast in the period that is eighteen (18) months following commencement of the Major Supply Failure. 
 1.19
“Manufacturing Line IP” has the meaning set forth in the IP Matters Agreement. 
 1.20 “Mark-Up” has the meaning set forth on Exhibit L to this Agreement. 
 1.21
“Materials” means Raw Materials and any coatings, lubrications or other materials used in Parent’s manufacturing of the Products. 

1.22 “Maximum Monthly Purchase” means, with respect to a given Fiscal Year and a Product Group, a quantity of units of such
Product Group equal to the Yearly Maximum Purchase for such Product Group in such Fiscal Year, divided by twelve (12). 

  

					
		  	Page 3 of 35	  	

 1.23 “Month” means a calendar month; provided that the first Month
shall commence on the Effective Date and shall end on the last day of the first full calendar month of the Term and the last Month shall end on the last day of the Term. 

1.24 “Monthly Delivery Date” means, with respect to a Month, (a) for Parent’s facility in Columbus, Nebraska, the
last Monday of such Month, and (b) for Parent’s facility in Tuas, Singapore, or Almaraz, Spain, the last business day of such Month. 

1.25 “Non-Conforming Use” means the sale, distribution, application or use of any
Product: (a) without incorporation into a SpinCo Product (e.g., the resale of standalone units of such Product); (b) with any device, product or system that is not a SpinCo Product; (c) for any purpose other than the manufacture of
SpinCo Products for use for the Permitted Purposes; or (d) in any other application or use that is inconsistent with (i) this Agreement, (ii) the intended use of such Product as specified in the Specifications or (iii) the
instructions (including handling instructions), if any, for such Product provided in writing by Parent to SpinCo. 
 1.26 “Permitted
Purpose” means: (a) use in the diabetes care sector; (b) sales to Parent for any purpose; (c) use in Public Health Programs at an amount substantially similar to the amount provided for such purpose by Parent immediately prior to the
Effective Date; or (d) sales of pen needles and less-than-one-(1)-mL syringes, in each case solely pursuant to relationships between SpinCo and the applicable third parties in effect as of the date hereof, including pursuant to the contracts set
forth on Exhibit M; provided that any such sales pursuant to this clause (d) shall not exceed $7.5 million in the aggregate in any fiscal year without the consent of Parent. 

1.27 “Person” has the meaning set forth in the Separation and Distribution Agreement. 

1.28 “Product” means any and all Product SKUs. 

1.29 “Product Group” means any and each of the following groups of Products: (a) syringe cannulas; (b) three
(3)-bevel pen needles; (c) five (5)-bevel thin-walled pen needles; and (d) five (5)-bevel extra-thin-walled pen needles. 
 1.30
“Product Price” means, with respect to a Product SKU, the price per unit of such Product SKU at the applicable time as set forth in Section 3.1. 

1.31 “Product SKU” means each individual cannula type listed on Exhibit A hereto, and more fully described in
the Specifications for such cannula type. 
 1.32 “Public Health Programs” means government,
non-profit and other public health programs designed to provide safe sharps products (e.g., syringes), including SpinCo Products, for users of such products who have limited access to sterile and safe sharps
products. 
 1.33 “Raw Materials” means stainless steel, including any additives, in such applicable grades as used to
manufacture the Products. 
 1.34 “Representatives” mean the employees, directors, officers, consultants, agents,
representatives and advisors (including attorneys and accountants) of a Person. 
 1.35 “Specifications” means, with respect
to each Product SKU, those specifications for such Product SKU attached as Exhibit B to this Agreement, as the same may be modified or supplemented from time to time as contemplated by Section 8.5. 

  

					
		  	Page 4 of 35	  	

 1.36 “SpinCo Product” means any product that (a) is listed on
Exhibit C hereto, (b) is developed, manufactured, marketed, offered for sale and/or sold by or on behalf of SpinCo for use for the Permitted Purposes, and (c) incorporates either (i) any Product or (ii) a third party
supplier’s cannula if, with respect to this clause (ii), the product is made using Manufacturing Line IP. 
 1.37 “Supply
Failure” means, on a Product SKU-by-Product SKU basis, with respect to a Product SKU, (a) a Major Supply Failure or (b) a failure of Parent, for any
reason, including a Force Majeure, to deliver those units of such Product SKU ordered by SpinCo that are required to be delivered by Parent in accordance with this Agreement (including Section 4.3 and Section 5.2), for more than thirty
(30) days past the applicable Monthly Delivery Date, but, notwithstanding anything to the contrary in this Agreement, excluding any such failure caused by the negligent acts or omissions of SpinCo or breach of this Agreement by SpinCo. 

1.38 “Termination Period” means the period of thirty-six (36) months immediately
preceding the effective date of any termination pursuant to Section 13.2 or Section 13.3. 
 1.39 “Termination
Year” means each of the three (3) twelve (12)-month periods during the Termination Period. 
 1.40 “Third
Party” has the meaning set forth in the Separation and Distribution Agreement. 
 1.41 “Visit CDA” means the
Confidential Disclosure Agreement for Facility Visits, the form of which has been agreed by the Parties and is attached hereto as Exhibit F, which form shall be executed and delivered by SpinCo prior to any inspection or audit of
Parent’s facilities as contemplated under this Agreement. 
 1.42 “Yearly Base Forecast Amount” means, with respect to
any Product Group or Product SKU in any Fiscal Year, the total units of such Product Group or Product SKU, as the case may be, set forth in the Yearly Base Forecast for such Fiscal Year. 

1.43 Additional Defined Terms. In addition to the terms defined above in this Article 1, the following terms have the respective
meanings assigned thereto in the sections indicated below: 
  

			
	 Defined Term
	  	 Section

	“Additional Equipment”	  	Section 3.5
		
	“Agreement”	  	Preamble
		
	“Capital Expenditures”	  	Section 3.5
		
	“Confidential Information”	  	Section 9.1
		
	“Debarred”	  	Section 8.6
		
	“Disclosing Party”	  	Section 9.1
		
	“Disqualified”	  	Section 8.6
		
	“Effective Date”	  	Preamble
		
	“Excluded”	  	Section 8.6
		
	“Export Control Laws”	  	Section 10.6(a)
		
	“Field Action”	  	Section 8.7
		
	“Force Majeure”	  	Article I of the Separation and Distribution Agreement

  

					
		  	Page 5 of 35	  	

			
	 “Indemnitee”
	  	Article I of the Separation and Distribution Agreement
		
	“Indemnifiying Party”	  	Article I of the Separation and Distribution Agreement
		
	“Ineligible”	  	Section 8.6
		
	“Maximum Allowable Purchase Cap”	  	Section 1.7(a)
		
	“Joint Operations Group”	  	Section 6.3
		
	“Latent Nonconformance”	  	Section 7.2
		
	“Liability Cap”	  	Section 12.5
		
	“Minimum Purchase Commitment”	  	Section 2.2(a)
		
	“Nonconformance”	  	Section 7.2
		
	“Party” and “Parties”	  	Preamble
		
	“Personnel”	  	Section 8.6
		
	“Potential Additional SpinCo Product”	  	Section 2.5
		
	“Pricing Date”	  	Section 3.1(b)
		
	“Purchase Order”	  	Section 4.2
		
	“Receiving Party”	  	Section 9.1
		
	“Parent”	  	Preamble
		
	“Parent Indemnitees”	  	Article I of the Separation and Distribution Agreement
		
	“Parent Safety Stock”	  	Section 6.1
		
	“Rolling Forecast”	  	Section 4.1
		
	“Safety Laws”	  	Section 10.2
		
	“Safety Products”	  	Section 10.2
		
	“Separation and Distribution Agreement”	  	Recitals
		
	“SpinCo”	  	Preamble
		
	“SpinCo Idemnitees”	  	Section 11.1
		
	“SpinCo Safety Stock”	  	Section 6.2
		
	“Term”	  	Section 13.1
		
	“Termination Base Year”	  	Section 4.6(b)(i)
		
	“Termination Purchase Commitment”	  	Section 2.2(b)
		
	“Third-Party Claim”	  	Section 4.5(a) of the Separation and Distribution Agreement
		
	“Transferring”	  	Section 10.6(a)
		
	“Updated Forecast”	  	Section 6.4(d)(iii)
		
	“U.S. Laws”	  	Section 10.6
		
	“Unauthorized Access”	  	Section 9.11
		
	“Year 1” “Year 2” “Year 3”	  	Section 1.12
		
	“Yearly Base Forecast”	  	Section 3.1(b)
		
	“Yearly Maximum Purchase”	  	Section 4.6

  

					
		  	Page 6 of 35	  	

 ARTICLE 2 

PURCHASE AND SALE; MINIMUM PURCHASE COMMITMENTS 

2.1 Purchase and Sale of Product. During the Term, SpinCo agrees to purchase certain quantities of Product from Parent in
compliance with the Purchase Commitments, and Parent agrees to sell such quantities to SpinCo, in each case, subject to the terms and conditions of this Agreement. SpinCo agrees that the Product will be used solely for incorporation into SpinCo
Products for use for the Permitted Purposes, and for no other purpose (including any Non-Conforming Use). 

2.2 Minimum Yearly Purchase Commitment. 

(a) Subject to Section 2.2(b), each Yearly Base Forecast submitted by SpinCo pursuant to Section 3.1(b) shall
include at least such units of each Product SKU as follows (each, a “Purchase Commitment”): 
 (i) subject to
Section 2.2(a)(ii), during each of Year 1, Year 2, Year 3, Year 4 and Year 5, such quantity of each Product SKU as is equal to the 2022 Base Forecast Amount with respect to such Product SKU; provided that, for the Purchase Commitment for
Year 1, the units of each Product SKU utilized by Parent’s diabetes care unit between October 1, 2021 and the Effective Date and set forth in Schedule 2.2(a)(i) shall count towards such Purchase Commitment; and 

(ii) during Year 6, all subsequent Fiscal Years during the Term, and any period subject to an Updated Forecast that modified a Yearly Base
Forecast under Section 6.4(d)(iii), [* * *] billion units of Product, apportioned among the Product SKUs in accordance with the proportion of each Product SKU ordered by SpinCo in the prior Fiscal Year. 

For clarity, SpinCo’s obligations to satisfy the Purchase Commitments for any Fiscal Year or Termination Year shall be without limitation of
SpinCo’s obligations to comply with its Yearly Base Forecasts under Section 3.1, Article 4 and Section 4.8. 
 (b) If, at any
time during the Term, SpinCo submits a Yearly Base Forecast that is inconsistent with the applicable Purchase Commitment, then: 
 (i) if
such Yearly Base Forecast is submitted for Year 2, Year 3, Year 4 or Year 5, then the provisions of Section 4.8(a) will apply; and 

(ii) if such Yearly Base Forecast is submitted for Year 6 or any subsequent Fiscal Year during the Term, then the provisions of
Section 13.2 will apply. 
 (c) Notwithstanding the foregoing, if this Agreement is terminated (a) by either Party for convenience
under Section 13.3 or (b) automatically for SpinCo’s failure to submit a Rolling Forecast satisfying the applicable Purchase Commitment under Section 13.2, then, without limiting any of SpinCo’s obligations to purchase
Product consistent with its Yearly Base Forecast and Rolling Forecasts in accordance with Section Article 4 and Section 4.8, SpinCo shall have the following minimum purchase obligations during the Termination Period (each, a
“Termination Purchase Commitment”) in lieu of the Purchase Commitments set forth above in Section 2.2(a): 
 (i)
during the first Termination Year, SpinCo shall purchase at least such units of each Product SKU as are equal to 75% of the otherwise applicable Purchase Commitment for such Product SKU; 

 

	[* * *] =	 [CONFIDENTIAL PORTION HAS BEEN OMITTED BECAUSE IT (I) IS NOT MATERIAL AND (II) WOULD BE
COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. 

  

					
		  	Page 7 of 35	  	

 (ii) during the second Termination Year, SpinCo shall purchase at least such units of each
Product SKU as are equal to 50% of the otherwise applicable Purchase Commitment for such Product SKU; and 
 (iii) during the final
Termination Year, SpinCo shall purchase at least such units of each Product SKU as are equal to 25% of the otherwise applicable Purchase Commitment for such Product SKU. 

For the avoidance of doubt, if any such Termination Year straddles Year 5 and Year 6, the Termination Purchase Commitment with respect to such Termination
Year shall be calculated based on the portion of such Termination Year corresponding to each such Fiscal Year and pro-rating the Purchase Commitment applicable to each such portion. 

2.3 Alternative Suppliers. For the avoidance of doubt, SpinCo may contract with other suppliers at any time after the Effective Date to
manufacture and supply any cannula that is either listed or not listed on Exhibit A for use in any industry, subject to SpinCo’s compliance with the Purchase Commitments or, as applicable, the Termination Purchase Commitments and the IP
Matters Agreement. 
 2.4 Additional Products. If SpinCo desires for Parent to manufacture and supply any cannula for use for any
Permitted Purpose and such cannula is not then listed on Exhibit A, SpinCo shall provide written notice thereof to Parent. Parent may, in its sole discretion, consent to manufacture and supply such cannula, in which case the Parties shall add
such cannula to Exhibit A as a new Product SKU (and such Product SKU will be placed into the appropriate Product Group (including an additional Product Group)); provided, however, that, with respect to the cannula set forth on
Exhibit K in development by Parent prior to the Effective Date, Parent shall consent to manufacture and supply such cannula, on mutually agreeable terms including pricing terms in accordance with the Accounting Principles. In the event that
Parent consents to manufacture and supply any new Product SKU, the Parties will negotiate in good faith the price and other terms and conditions applicable to such manufacture and supply under this Agreement. For the avoidance of doubt,
(a) Parent will have no obligation to manufacture and supply to SpinCo any such new Product SKU unless and until the Parties have updated Exhibit A to include such new Product SKU and have agreed on all terms and conditions applicable to
the manufacture and supply of such new Product SKU under this Agreement and (b) due to the non-exclusive arrangement of this Agreement and subject to SpinCo’s Purchase Commitments or, as applicable,
the Termination Purchase Commitment, SpinCo shall have no obligation to request that Parent manufacture and supply any cannula for use for the Permitted Purposes (or otherwise), which cannula is not then listed on Exhibit A. 

2.5 Additional SpinCo Products. If SpinCo desires to incorporate Product into an end product developed, manufactured, marketed, offered
for sale and/or sold by SpinCo or its Affiliates for use for any Permitted Purpose, but that is not then listed on Exhibit C (a “Potential Additional SpinCo Product”), SpinCo shall provide written notice thereof to Parent
within a reasonable amount of time (but no less than ninety (90) days) prior to the date that SpinCo intends to commence incorporating such Product into the applicable Potential Additional SpinCo Product. Unless Parent is restricted, by
applicable Laws or existing contractual obligations, from supplying Product to SpinCo for incorporation into such Potential Additional SpinCo Product, such Potential Additional SpinCo Product shall become a SpinCo Product and the Parties shall
update Exhibit C to include such new SpinCo Product. 

  

					
		  	Page 8 of 35	  	

 2.6 Discontinued Product. Parent will not discontinue the manufacture and supply of
any Product SKU without SpinCo’s prior written consent. Following SpinCo’s consent, if applicable, the Parties shall update Exhibit A to remove such Product SKU, and SpinCo shall no longer have the right to place Purchase Orders
with respect to such Product SKU. 
 ARTICLE 3 

PURCHASE PRICE 
 3.1
Purchase Price. 
 (a) With respect to Year 1, for each Product SKU purchased by SpinCo from Parent, SpinCo shall pay to Parent
the price for such Product SKU as set forth in Exhibit D attached hereto, subject to any applicable adjustments set forth in this Article 3. 

(b) With respect to each Fiscal Year during the Term following Year 1, on or before May 31 of the prior Fiscal Year, SpinCo shall submit
to Parent an initial forecast of orders by Product SKU for such Fiscal Year, which must be consistent, with respect to all applicable Months, to the Rolling Forecast last submitted by SpinCo (subject to the permitted variances under Section Article
4) and shall be deemed to be the Rolling Forecast for the period starting on October 1 of such Fiscal Year and ending on September 30 of such Fiscal Year (each such forecast and, with respect to Year 1, the 2022 Base Forecast, a
“Yearly Base Forecast”). Parent shall thereafter update the price list set forth on Exhibit D to reflect any changes to the pricing for each Product SKU based on the Yearly Base Forecast for such Fiscal Year and the
Accounting Principles, and shall submit such updated price list to SpinCo, with reasonably detailed documentation supporting any changes, no later than June 30 of the Fiscal Year in which such Yearly Base Forecast was submitted (the
“Pricing Date”). Such updated price list shall be deemed to be attached to this Agreement as Exhibit D, and shall supersede and replace the prior version of Exhibit D, effective as of the start of the applicable Fiscal
Year. In the event that SpinCo notifies Parent on or before July 31 of a Fiscal Year that the Product Price for one or more Product SKUs on the updated price list submitted by Parent for the subsequent Fiscal Year does not reflect changes
consistent with the Accounting Principles, the Chief Financial Officers (or officers with equivalent duties) of each of the Parties will discuss and work in good faith to resolve the dispute within ten (10) business days. If such officers
cannot resolve the matter within such time period, either Party can escalate the matter to an independent third party auditor mutually agreed upon by the Parties. Any such independent third party auditor will only be charged with determining whether
the disputed Product Price(s) has been calculated in a manner consistent with Accounting Principles and, if not, what such Product Price(s) should be if calculated in such a manner. The determination of such independent third party auditor shall be
binding upon the Parties and such auditor will be instructed and authorized by the Parties to issue a binding resolution to the dispute no later than September 30 (i.e., prior to the Fiscal
Year for which the price list is relevant). In the event that, despite the foregoing sentence, a Product Price for a Product SKU is not determined by September 30, during the pendency of the dispute resolution procedure, the Product Price for
such Product SKU shall be the higher of (i) the applicable Product Price for such Product SKU during the most recent Fiscal Year and (ii) SpinCo’s determination of the Product Price for such Product SKU in its application of the
Accounting Principles and, following resolution of the disputed prices, Parent will apply a credit to future invoices issued to SpinCo under this Agreement if the Product Price for such Product SKU is determined to be lower and Parent will invoice
SpinCo for any underpaid amount if the Product Price for such Product SKU is determined to be higher, in each case when compared to the Product Price for such Product SKU during the dispute. 

  

					
		  	Page 9 of 35	  	

 3.2 Stainless Steel Cost Adjustment. If, in any Fiscal Year, the cost of
stainless steel increases or decreases by more than five percent (5%) as compared to the cost of stainless steel as of the Pricing Date for such Fiscal Year, as determined based on the MEPS Stainless Steel 304 index, then Parent shall adjust the
Product Price for each Product SKU by an amount reflecting the aggregate increase or decrease in the cost of stainless steel, on a pro-rata basis based on the cost of stainless steel in proportion to the
overall Product Price for each Product SKU. Parent shall notify SpinCo in writing of any such Product Price adjustment due to the cost of stainless steel by submitting an updated price list to SpinCo at least fifteen (15) days prior to the
start of the next Calendar Quarter. Such updated price list shall be deemed to be attached to this Agreement as Exhibit D, and shall supersede and replace the prior version of Exhibit D, effective as of the start of the next Calendar
Quarter. Following an initial adjustment of the Product Price for a Product SKU under this Section 3.2 in a Fiscal Year, Parent shall adjust the Product Price for such Product SKU through the same mechanic as set forth above if there are
further increases or decreases to the cost of stainless steel in such Fiscal Year, as determined based on the MEPS Stainless Steel 304 index; provided that Parent will not make any such changes unless the further increase or decrease, as
applicable, in the cost of stainless steel in such Fiscal Year exceeds 0.5% as compared to the cost of stainless steel as of the date of the last adjustment pursuant to this Section 3.3. For the avoidance of doubt, any increase or decrease in
the cost of stainless steel, as determined based on the MEPS Stainless Steel 304 index, between the Pricing Date and the start of the subsequent Fiscal Year that would give rise to a Product Price adjustment under this Section 3.3 shall not be
reflected in the Product Price for each Product SKU until the second Calendar Quarter of such Fiscal Year. 
 3.3 Regulatory Cost
Adjustment. In addition to the price adjustments set forth in Section 3.2, if, at any time during the Term, there is a change in applicable Law or other legal or regulatory requirement that alters the costs of manufacture of a Product SKU,
then Parent shall adjust the Product Price for such Product SKU by an amount reflecting any related adjustment to the costs allocable to the manufacture of such Product SKU, provided that, if such change in applicable Law or other legal or
regulatory requirement alters the costs of manufacture of both one or more Product SKU(s) and one or more other product(s) of Parent that are not Products, the applicable costs will be equitably allocated between or among such Product SKU(s) and
such other product(s). Parent shall promptly notify SpinCo in writing of any such Product Price adjustment due to a change in applicable Law or other legal or regulatory requirement by submitting an updated price list to SpinCo at least fifteen
(15) days prior to the start of the next Month. Such updated price list shall be deemed to be attached to this Agreement as Exhibit D, and shall supersede and replace the prior version of Exhibit D, effective as of the start of
the next Month. Upon request, Parent will provide SpinCo with such documentation as SpinCo may reasonably request itemizing and evidencing the increase or decrease in costs based on such change to the manufacturing process and the allocation thereof
to the manufacture of the Products. 

  

					
		  	Page 10 of 35	  	

 3.4 Cost Improvement Program. Parent will continue its cost improvement program for
cannula manufacturing, with the goal, but not a guarantee, of cost reduction. The Joint Operations Group shall discuss cannula production cost improvements in its quarterly meetings until commencement of the Termination Period. The Parties will also
discuss in good faith appropriate allocations of any resulting savings, including potential impact on Product Price, after deducting actual, direct and documented costs of the improvement implementation, with any such allocations to be mutually
agreed upon by the Parties. 
 3.5 Capital Cost Recovery. If, at any time during the Term, Parent invests in any new capital
expenditures to satisfy increased demand from SpinCo or to manufacture a new Product SKU as contemplated by Section 2.4 (“Capital Expenditures”), including new equipment, molds, mold presses, and associated testing
(“Additional Equipment”), then the remaining unamortized amount of such Capital Expenditures shall be treated as follows, at SpinCo’s election: (a) on or after the effective date of termination, Parent shall invoice SpinCo
for such amount, less the salvage value of the applicable Additional Equipment (as reasonably demonstrated by documentation provided by Parent to SpinCo, which documentation shall constitute Confidential Information of Parent), and SpinCo shall pay
to Parent such invoiced amount within thirty (30) days of receipt of such invoice, or (b) such amount will be divided among and added to the Product Price for SpinCo’s remaining purchases during the Termination Period, as applicable;
provided, however, that Parent shall use reasonable efforts to reduce the remaining unamortized amount of such Capital Expenditures by utilizing, to the extent reasonably practicable, the Additional Equipment or components thereof in
Parent’s other businesses, in which case such remaining unamortized amount shall be reduced to account for such alternative utilization. Upon SpinCo’s request, Parent will confirm as to whether any such alternative utilization has occurred
and the applicable calculation of such remaining unamortized amount in light of such utilization. For the avoidance of doubt, Parent shall be responsible for the costs of maintenance, upkeep and replacement, as applicable, of any Parent equipment
used in the manufacture of Products as of the Effective Date. 
 3.6 Expediting Costs. Any incremental costs for the manufacture and
supply of Product resulting from a requirement to expedite such manufacture and supply shall be borne exclusively by the Party responsible for such requirement. 

3.7 Pricing Commitment. At all times during the Term, the Product Price for each Product SKU hereunder shall be no less favorable than
the price contemporaneously charged by Parent to any similarly situated, unaffiliated third party customer (for clarity, not including any subcontractor engaged by Parent or its Affiliates) that purchases equal to or less than a similar volume of
such Product SKU over the course of a contemporaneous twelve-month period. Any change in a Product Price pursuant to this clause will only be applied on a prospective basis.

ARTICLE 4 
 FORECASTS AND
ORDERS 
 4.1 Rolling Forecast. SpinCo shall furnish Parent with a rolling twelve (12)-Month forecast of SpinCo’s Product
orders by Product SKU (the “Rolling Forecast”). The Rolling Forecast shall be updated monthly and provided to Parent by the fifteenth (15th) day of the Month prior to the first Month of such Rolling Forecast; provided,
however, that the Yearly Base Forecast will be deemed to be the Rolling Forecast that would otherwise be submitted on September 15th of the Fiscal Year in which the Yearly Base Forecast was
submitted. All Rolling Forecasts must be consistent with the applicable Yearly Maximum Purchase and Maximum Monthly Purchase. The initial Rolling Forecast is attached to this Agreement as Exhibit E. The first two (2) Months of each
Rolling Forecast shall be binding upon SpinCo by Product Group and, except as otherwise agreed by the Parties, by Product SKU. Months three (3) through twelve (12) of each Rolling Forecast are
non-binding; provided, however, that: 

  

					
		  	Page 11 of 35	  	

 (a) on a Product Group-basis, any revisions in a subsequent Rolling Forecast to Months three
(3) through twelve (12) of the prior Rolling Forecast with respect to a Product Group will require, and will not be effective without, the following advance notice in writing from SpinCo to Parent: (i) for revisions less than two
percent (2%) to the amount of such Product Group to be ordered in a Month, one (1) month’s advance notice, (ii) for revisions between two percent (2%) and five percent (5%) to the amount of such Product Group to be ordered in a Month,
three (3) months’ advance notice and (iii) for revisions over five percent (5%) to the amount of such Product Group to be ordered in a Month, six (6) months’ advance notice; and 

(b) on a Product SKU-basis, any revisions in a subsequent Rolling Forecast to Months three
(3) through twelve (12) of the prior Rolling Forecast with respect to a Product SKU within a specified Product Group will require, and will not be effective without, the following advance notice in writing from SpinCo to Parent:
(i) for revisions less than ten percent (10%) to the amount of such Product SKU to be ordered in a Month, no advance notice (i.e., such change may be made in the applicable Purchase Order), (ii) for revisions between ten percent (10%)
and twenty-five percent (25%) to the amount of such Product SKU to be ordered in a Month, three (3) months’ advance notice and (iii) for revisions between twenty-five percent (25%) and fifty percent (50%) to the amount of such Product
SKU to be ordered in a Month, six (6) months’ advance notice. 
 To the extent that a Rolling Forecast is not communicated by SpinCo by the
fifteenth (15th) day of the then-current Month, the Parties agree that the Rolling Forecast issued in the previous Month will be given effect as if it were submitted in the current Month (with Months shifted as needed to adjust for the fact that the
Rolling Forecast was issued for a prior Month). 
 4.2 Purchase Orders. Purchase orders for Product under this Agreement (each, a
“Purchase Order”) shall be delivered monthly by SpinCo to Parent no more than three (3) months and no less than two (2) months prior to the Monthly Delivery Date, and shall indicate orders by Product SKU and Product Group.
Notwithstanding anything to the contrary in this Agreement, in no event shall any individual SpinCo facility issue more than one (1) Purchase Order in any Month. All orders of a Product SKU shall be by units of such Product SKU, and Parent will
fill such orders to the nearest complete Cartridge of such Product SKU, in accordance with the procedure set forth on Exhibit H. 

4.3 Purchase Order Confirmation. Parent shall confirm or, subject to the terms of this Agreement, reject, each Purchase Order within
fifteen (15) days of receipt, which confirmation, if given, shall confirm the applicable Month of delivery, the quantity of each Product SKU ordered and the applicable Product Price therefor. Parent shall not have the right to reject any
Purchase Order that is consistent with the most recent binding forecast applicable to such Month; provided, however, that if any Purchase Order contains (a) quantities of a Product Group in excess of the Maximum Monthly Purchase
for the applicable Month for such Product Group or (b) quantities of a Product SKU in excess of the most recent binding forecast for such Month for such Product SKU in the Rolling Forecast, Parent shall have no obligation to supply such excess
quantities except to the extent it confirms in writing to SpinCo its agreement, in its sole discretion (and subject to such pricing as may be negotiated by the Parties), to supply such excess quantities (in whole or in part). 

  

					
		  	Page 12 of 35	  	

 4.4 Delivery Date. In addition, with respect to each Purchase Order confirmed by
Parent, no later than one (1) week prior to the delivery date with respect to any Product SKUs set forth in such Purchase Order, Parent shall confirm electronically to SpinCo (a) such delivery date with respect to such Product SKUs, which
shall in no event be later than the Monthly Delivery Date for the applicable Month, (b) the location of such delivery (i.e., Parent’s facility in Columbus, Nebraska, Almaraz, Spain and/or Parent’s facility in Tuas, Singapore)
and (c) the approximate units of Product SKUs set forth in such Purchase Order that will be delivered on such date at such location. 

4.5 Monthly Shortfalls. Subject to Section 6.4, if, in any Month, the quantities of Product, by Product SKU, ordered in all
Purchase Orders submitted in such Month are less than the quantities of such Product SKU set forth in the binding forecast for such Month submitted under Section Article 4, SpinCo must order such shortfall amount of units of such Product SKU in
Purchase Orders submitted in the next two (2) Months following the Month in which such shortfall amount arose, subject to the applicable Maximum Monthly Purchase. To the extent SpinCo fails to order such shortfall amount during such two
(2) month period, SpinCo will be deemed to have issued to Parent a Purchase Order for the units of each Product SKU that are subject to such shortfall, subject to the applicable Maximum Monthly Purchase, Parent will deliver such units of
Product SKU pursuant to such deemed Purchase Order in accordance with the terms of this Agreement and SpinCo will pay the Product Price for such units of Product SKU in accordance with this Agreement. 

4.6 Yearly Maximum Purchase. Notwithstanding anything contained in a Rolling Forecast or this Agreement to the contrary, except as
otherwise mutually agreed by the Parties in writing, Parent shall have no obligation, in any Fiscal Year, to supply Products to SpinCo, by Product Group, in excess of the following quantities (each, a “Yearly Maximum Purchase”):

 (a) during each Fiscal Year other than a Termination Year, such quantity of each Product Group as is equal to 110% of the Yearly Base
Forecast Amount for such Product Group for such Fiscal Year, provided that, for clarity, Products supplied to SpinCo under the 2022 Base Forecast prior to the Effective Date shall be deemed supplied to SpinCo for purposes of determining
whether the Yearly Maximum Purchase for Year 1 has been achieved; 
 (b) notwithstanding clause (a), during the Termination Period, such
quantity as follows: 
 (i) during the first Termination Year, such quantity of units of each Product Group as is (1) with respect to
the period of such Termination Year that coincides with a Fiscal Year for which there is a Yearly Base Forecast, the Yearly Base Forecast Amount of such Product Group for the remainder of such Fiscal Year that falls within such Termination Year and
(2) for the remainder of such Termination Year (if any), seventy-five percent (75%) of the Allowable Purchase Cap for such Product Group in such Fiscal Year immediately prior to the Fiscal Year in which the notice (or deemed notice) of
termination occurred (the “Termination Base Year”), pro-rated for such remainder of the Termination Year; 

  

					
		  	Page 13 of 35	  	

 (ii) during the second Termination Year, such quantity of units of each Product Group as is
equal to fifty percent (50%) of the Allowable Purchase Cap for such Product Group in the Termination Base Year; and 
 (iii) during the
final Termination Year, such quantity of units of each Product Group as is equal to twenty-five percent (25%) of the Allowable Purchase Cap for such Product Group in the Termination Base Year; 

provided that, except as otherwise mutually agreed by the Parties in writing or under Section 6.4(d)(iv), the Yearly Maximum Purchase for each
Fiscal Year shall be subject to the Allowable Purchase Cap. 
 4.7 Capacity Increases. Notwithstanding anything to the contrary in
this Agreement, until SpinCo’s first delivery of a Yearly Base Forecast that includes at least [* * *] billion units of Product less than the Maximum Allowable Purchase Cap, SpinCo may notify Parent no more than once per twelve (12)-month
period during the Term that SpinCo desires for Parent to increase its manufacturing capacity and make a corresponding increase to the Maximum Allowable Purchase Cap and the Yearly Maximum Purchases for one or more Product Groups and corresponding
Product SKUs. Following the Parties’ agreement upon mutually agreeable terms with respect to any such capacity increase, including the allocation of costs with respect thereto and the anticipated timing of completion thereof (which shall be no
less than [* * *] months from the date of such agreement), Parent will undertake such capacity increase in accordance with such agreed terms, at a facility of Parent’s choosing, subject to the timely payment by SpinCo of all costs allocated to
SpinCo associated therewith; provided that at no time will Parent have any obligation to increase its manufacturing capacity to produce more than [* * *] billion units of Product in any [* * *] month period. 

4.8 Annual Reconciliations. 

(a) If, with respect to a Fiscal Year, SpinCo has failed to submit a Yearly Base Forecast for each Product SKU that is equal or more than the
Purchase Commitment (or Termination Purchase Commitment, as applicable) for such Product SKU for such Year, following the end of such Fiscal Year, the Joint Operations Group shall review the aggregate Product ordered by SpinCo by Product SKU and the
Mark-Up received by Parent based on such orders in such Fiscal Year (treating as received any Mark-Up that was not received on account of any underruns pursuant to
Section 5.2). If Parent has received less than one hundred percent (100%) of the Mark-Up for a Product SKU that Parent would have received had SpinCo submitted and complied with a Yearly Base Forecast for
such Product SKU equal to the Purchase Commitment for such Product SKU for such Fiscal Year, then SpinCo will pay to Parent a payment that will be calculated, on a Product
SKU-by-Product SKU basis, as the Lost Mark-up for such Fiscal Year as a result of such failure. Any amount owed by SpinCo under
this Section 4.8(a) shall be payable by SpinCo within ninety (90) days of receipt of an invoice therefor from Parent. 
 (b)
Following the end of each Fiscal Year of this Agreement, in the event that SpinCo failed to order any Product SKU in the quantities set forth in the Yearly Base Forecast for such Fiscal Year, the Joint Operations Group shall review the aggregate
Product ordered by SpinCo by Product SKU and the Absorption and Mark-Up received by Parent based on such orders in such Fiscal Year (treating as received any Absorption or
Mark-Up that was not received on account of any underruns pursuant to Section 5.2). If Parent has received less than one hundred percent 

  

	[* * *] =	 [CONFIDENTIAL PORTION HAS BEEN OMITTED BECAUSE IT (I) IS NOT MATERIAL AND (II) WOULD BE
COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. 

  

					
		  	Page 14 of 35	  	

 
(100%) of either or both of the Absorption or Mark-Up with respect to a Product SKU that Parent would have received had SpinCo complied with the Yearly
Base Forecast for such Product SKU for such Fiscal Year, then SpinCo will pay to Parent a payment that will be calculated, on a Product SKU-by-Product SKU basis, as
(a) the Absorption Variance for such Fiscal Year (if any), plus (b) the Lost Mark-up for such Fiscal Year (if any and to the extent not owed under Section 4.8(a)), in each case ((a) and
(b)), as a result of such shortfall. Notwithstanding the foregoing, if a Major Supply Failure occurs and the Updated Forecast modifies the Yearly Base Forecast under Section 6.4(d)(iii), the annual reconciliation under this Section 4.8(b)
shall not occur until following the end of the twenty-four (24)-month period covered by the Updated Forecast, and at such time shall occur with respect to all periods between the last such annual reconciliation and the end of such twenty-four
(24)-month period (and thereafter, the annual reconciliation shall be conducted following each Fiscal Year in accordance with this Section 4.8(b)). Any amount owed by SpinCo under this Section 4.8(b) shall be payable by SpinCo within
ninety (90) days of receipt of an invoice therefor from Parent. 
 4.9 Conflicts. No provision in any Purchase Order, Purchase
Order confirmation or invoice that purports to impose different or additional terms or conditions than those set forth in this Agreement shall be of any force or effect. 

ARTICLE 5 
 SHIPMENT AND
DELIVERY; INVOICES 
 5.1 Delivery. Any Product supplied under this Agreement shall be delivered FCA (Incoterms
2010) Parent’s facility in Columbus, Nebraska, or Tuas, Singapore, as applicable, or at BD’s discretion, pen needle Product supplied under this Agreement intended for Dun Laoghaire or Suzhou 3 may be delivered FCA Parent’s
facility in Almaraz, Spain. SpinCo, at its own expense, shall be responsible for loading, transporting, and if applicable, exporting the Product from the foregoing location to SpinCo’s facility. Title to Product and risk of loss or damage shall
pass to SpinCo upon delivery to SpinCo, or its agents, FCA (Incoterms 2010) Parent’s facility in accordance with this Section. 

5.2 Overruns and Underruns. Notwithstanding anything to the contrary in this Agreement, on a Product SKU-by-Product SKU basis, the permissible overrun and underrun of a given Product SKU delivered by Parent in any given Month shall not exceed plus or minus five percent (5%)
of the confirmed, aggregate amount of units of such Product SKU actually ordered in that Month, provided that the yearly overrun or underrun may not exceed plus or minus two percent (2%) of the confirmed, aggregate amount of units of such
Product SKU actually ordered in any Fiscal Year. For the avoidance of doubt, such permitted overrun and underrun amounts will be calculated on a Product SKU-by-Product
SKU (not manufacturing site-by-manufacturing site) basis. 

5.3 Cartridges. At all times, Parent shall retain title to the Cartridges, and SpinCo acknowledges and agrees that such Cartridges are
proprietary to Parent. In no event shall SpinCo transfer any Cartridge to a third party or show or provide access to a Cartridge to a third party. SpinCo shall solely use Cartridges pursuant to Parent’s written instructions. SpinCo shall return
empty Cartridges to Parent on a periodic basis as directed by Parent, at Parent’s cost. All intellectual property covering or embodied in the Cartridge, as well as the tangible Cartridge itself is considered the “Restricted Confidential
Information” of Parent. 

  

					
		  	Page 15 of 35	  	

 5.4 Cannula Lubricant. For [* * *] years following the Effective Date (unless
otherwise terminated by SpinCo), Parent shall supply to SpinCo cannula lubricant, such cannula lubricant to be solely used in manufacturing lines incorporating Manufacturing Line IP and for the sole purpose of manufacturing Products or any cannula
supplied to SpinCo by an alternate third party supplier, subject to the IP Matters Agreement, on the terms and subject to the conditions set forth on Exhibit I hereto. 

5.5 Invoices. Parent shall invoice SpinCo for the delivered quantity upon each delivery of Product, and SpinCo shall pay the full
balance of each invoice in US Dollars within ninety (90) days after delivery by Parent to SpinCo. All such invoices shall be forwarded to the attention of the following: 

Brian Capone 
 VP, Corporate
Controller and Chief Accounting Officer – embecta 
 1 Becton Drive (F-425) 

Franklin Lakes, NJ 07417 
 email:
brian.capone@bd.com 
 5.6 Taxes. To the extent that Products purchased under this Agreement are subject to any consumption-based
taxes (e.g., sales, use and/or value-added taxes), payment of such taxes is the responsibility of SpinCo. Parent shall have the right to withhold taxes where required to do so by applicable Laws. 

ARTICLE 6 
 ASSURANCE OF
SUPPLY
 6.1 Parent Safety Stock. During the Term of this Agreement, Parent agrees to hold and store approximately [* * *] weeks
of safety stock of Products, on a Product Group basis (“Parent Safety Stock”). Parent may adjust the amount of Parent Safety Stock to reflect material changes in Product volume as may be indicated in the Rolling Forecast. During the
Term of this Agreement, at Parent’s option, the Parent Safety Stock may be used to satisfy Purchase Orders in excess of the Yearly Maximum Purchase or the Maximum Monthly Purchase, or to avoid or remedy a Supply Failure. Parent shall use its
commercially reasonable efforts to replenish any Parent Safety Stock as soon as possible following its use thereof, but in any event no later than three (3) months following such use. 

6.2 SpinCo Safety Stock. During the Term of this Agreement, SpinCo agrees to hold and store no less than [* * *] weeks of safety stock
of Products, on a Product Group basis (“SpinCo Safety Stock”). SpinCo shall routinely update the SpinCo Safety Stock to reflect SpinCo’s changing volume requirements. During the Term of this Agreement, unless otherwise agreed
to by Parent, upon Parent’s notification of a Supply Failure, SpinCo shall use the SpinCo Safety Stock to fulfill any undelivered Product in accordance with the Rolling Forecast in effect for the Month in which the notification occurred.
Following the resolution of any Supply Failure, SpinCo shall replenish any SpinCo Safety Stock as soon as possible following its use thereof, but in any event no later than six (6) months following such use, and subject to the Yearly Maximum
Purchases (and, for clarity, it shall not constitute a breach of this Section 6.2 if SpinCo is unable to replenish any SpinCo Safety Stock within such six (6)-month period as a result of the Yearly Maximum Purchases, provided that SpinCo
replenishes such SpinCo Safety Stock as soon as possible in light of the Yearly Maximum Purchases). 
  

	[* * *] =	 [CONFIDENTIAL PORTION HAS BEEN OMITTED BECAUSE IT (I) IS NOT MATERIAL AND (II) WOULD BE
COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. 

  

					
		  	Page 16 of 35	  	

 6.3 Joint Operations Group. Promptly following the Effective Date, the Parties shall
form a joint operations group (the “Joint Operations Group”). The Joint Operations Group will be comprised of three representatives from each Party, who will meet at least once quarterly, in each case, by telephone, videocall or in
person. Each Party may change its representatives on the Joint Operations Group by written notice to the other Party. The Joint Operations Group will discuss any concerns, issues, cost improvements, long-term volume requirements and capacity issues
by Product SKU or performance updates, and will have such other responsibilities as are set forth in this Agreement. The Joint Operations Group is intended to facilitate communication between the Parties and to aid the Parties in long-range planning
but shall have no power to bind either Party or modify the terms of this Agreement. 
 6.4 Supply Failures. 

(a) Notice. Parent shall promptly notify SpinCo of any event that appears reasonably likely to result in a Supply Failure with respect
to a Product SKU. 
 (b) Remediation Plan. Within five (5) business days of Parent’s notification to SpinCo under
Section 6.4(a), Parent will prepare a remediation plan intended to resolve the Supply Failure within thirty (30) days of such notification and will inform SpinCo of such plan in reasonable detail, subject to redaction for highly sensitive
or trade secret information. If such Supply Failure involves a partial (but not total) inability to supply ordered Product SKU due to a shortage of Raw Materials or a shortage of such Product SKU, Parent will include in such remediation plan a
proposal for an equitable allocation of Raw Materials or units of such Product SKU among all of Parent’s requirements with respect to such Raw Materials or Products, pro rata based on SpinCo’s usage and any other usage of such Raw
Materials or Products for the twelve (12)-month period prior to such Supply Failure, and will use commercially reasonable efforts to carry out such equitable allocation. Parent shall keep SpinCo reasonably informed of Parent’s progress in
executing on any such remediation plan. 
 (c) Effects of Major Supply Failure. Notwithstanding anything provided herein to the
contrary, if a Major Supply Failure occurs, SpinCo will be excused from (i) the Purchase Commitments (or Termination Purchase Commitments, as applicable), (ii) SpinCo’s obligation to comply with the Yearly Base Forecast as set forth in
Section Article 4 and Section 4.8 and (iii) SpinCo’s obligations with respect to monthly shortfalls pursuant to Section 4.5, in each case, solely to the extent of such Product SKUs affected by such Major Supply Failure during the
occurrence of such Major Supply Failure and for ninety (90) days after Parent’s notice pursuant to Section 6.4(d) that such Major Supply Failure has been remedied. 

(d) Resolution and Resumption of Supply. 

(i) Parent will notify SpinCo in writing when the underlying issue causing the Major Supply Failure is remedied and Parent is able to
recommence its manufacture and supply of the Product SKUs affected by such Major Supply Failure. 
 (ii) Effective as of the ninetieth
(90th) day following such notice from Parent, SpinCo will be subject to the Purchase Commitments described in Section 2.2(a)(ii) (or Termination Purchase Commitments, as applicable) with respect to such affected Product SKUs, subject to
Section 6.4(d)(iii). 

  

					
		  	Page 17 of 35	  	

 (iii) Within thirty (30) days after Parent’s notice that the underlying issue is
remedied, SpinCo shall submit to Parent an updated Rolling Forecast for the period starting on the ninetieth (90th) day following such notice from Parent (the “Updated Forecast”), provided that such Updated Forecast shall
include the period starting on such day and ending twenty-four (24) months thereafter. Such Updated Forecast shall be consistent with the Purchase Commitment in Section 2.2(a)(ii) (or Termination Purchase Commitments, as applicable) and
Allowable Purchase Cap in the Fiscal Year during which the applicable Major Supply Failure occurred, in each case reduced pro rata to account for the portion of the applicable Fiscal Year (or Termination Year, as applicable) during which
Purchase Commitments (or Termination Purchase Commitments, as applicable) were not in effect. If such Updated Forecast is consistent with the Yearly Base Forecast for such Fiscal Year for the applicable Months remaining in such Fiscal Year, then
there will be no change to the then-current price list set forth on Exhibit D and the Yearly Base Forecast will stay in place and be unmodified going forward. If such Updated Forecast is not consistent with the Yearly Base
Forecast for such Fiscal Year for the applicable Months remaining in such Fiscal Year (or if the applicable Yearly Base Forecast did not include the applicable Product SKU(s) because the Major Supply Failure commenced prior to submission of the
Yearly Base Forecast), then the Yearly Base Forecast will be deemed to be modified as set forth in such Updated Forecast, and Parent shall thereafter update the price list set forth on Exhibit D to reflect any changes to the pricing for each
Product SKU based on such Updated Forecast and the Accounting Principles, and shall submit such updated price list to SpinCo no later than the sixtieth (60th) day following such notice from Parent. Such updated price list shall be deemed to be
attached to this Agreement as Exhibit D, and shall supersede and replace the prior version of Exhibit D, effective as of the ninetieth (90th) day following such notice from Parent. SpinCo may, within thirty (30) days of receipt of
the updated price list from Parent, dispute the application of Accounting Principles by Parent in calculating the prices set forth on such price list by notice to Parent in which case the dispute resolution procedure set forth in Section 3.1(b)
shall apply. During the pendency of the dispute resolution procedure, the Product Price shall be the higher of (i) the Product Price prior to the Major Supply Failure and (ii) SpinCo’s determination of the Product Price in its
application of the Accounting Principles and, following resolution of the disputed prices, Parent will apply a credit to future invoices issued to SpinCo under this Agreement if the Product Price is determined to be lower and Parent will invoice
SpinCo for any underpaid amount if the Product Price is determined to be higher, in each case when compared to the Product Price during the dispute. For clarity, Yearly Base Forecasts will continue to be submitted by SpinCo during the 24-month period covered by the Updated Forecast and such Yearly Base Forecast must be no less, on a month-by-month and SKU-by-SKU basis, then the relevant portion of the Updated Forecast. 

(iv) During the twenty-four (24)-month period covered by the Updated Forecast, the Allowable Purchase Cap will remain at the level applicable
prior to occurrence of the Major Supply Failure. Following such twenty-four (24)-month period for the remainder of the applicable Fiscal Year, the Allowable Purchase Cap for such remainder of the applicable Fiscal Year will be (a) the Maximum
Allowable Purchase Cap pro-rated for the applicable partial Fiscal Year if (i) the Allowable Purchase Cap in the Fiscal Year in which the Major Supply Failure occurred was the Maximum Allowable Purchase
Cap and (ii) the Yearly Base Forecast for the remainder of the applicable Fiscal Year is not more than or equal to [* * *] billion units less than such Maximum Allowable Purchase Cap (if such Yearly Base Forecast is proportionally adjusted for
a 12-month period), (b) in all other instances, the lower of (i) the Allowable Purchase Cap for the 

  

	[* * *] =	 [CONFIDENTIAL PORTION HAS BEEN OMITTED BECAUSE IT (I) IS NOT MATERIAL AND (II) WOULD BE
COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. 

  

					
		  	Page 18 of 35	  	

 
Fiscal Year during which the Major Supply Failure occurred and (ii) 110% of the then-current Yearly Base Forecast Amount pro-rated for the applicable
partial Fiscal Year. The Allowable Purchase Cap for all subsequent Fiscal Years shall be as set forth in Section 4.6. Also, following such twenty-four (24)-month period covered by an Updated Forecast that modified the Yearly Base Forecast under
Section 6.4(d)(iii), the Purchase Commitment for the remainder of the applicable Fiscal Year will be a pro-rated amount of the Purchase Commitment for such Fiscal Year (if no Updated Forecast was in place
during such Fiscal Year). 
 (e) SpinCo Remedies. Without limiting any other remedy under this Agreement or applicable Laws, in no
event shall SpinCo have the right to terminate this Agreement under Section 13.4 as a result of any Supply Failure, except that SpinCo may terminate this Agreement under Section 13.4, on a Product SKU-by-Product SKU basis with respect to the Product SKU to which a Major Supply Failure relates, if a Major Supply Failure Termination Event has occurred with respect to such Product SKU. In addition,
notwithstanding anything to the contrary under this Agreement, the Parties agree and acknowledge that, for a Major Supply Failure that is not a Major Supply Failure Termination Event, (i) SpinCo’s sole and exclusive remedy under this
Agreement is to provide an Updated Forecast under this Section 6.4, and (ii) SpinCo’s sole and exclusive remedy under the IP Matters Agreement is a waiver of the upfront and incremental royalty fees, as applicable, otherwise due to
Parent on cannula sourced from a Third Party during such Major Supply Failure; provided that such waiver is applicable for a maximum of two (2) years from the date of the commencement of such Major Supply Failure (it being understood
that if Third Party-sourced cannula are being used with Manufacturing Line IP following such two (2) year waiver, then the upfront will be due and royalty fees will be due on future sales, as further described in the IP Matters Agreement). 

ARTICLE 7 
 PRODUCT
WARRANTY 
 7.1 Limited Product Warranty. Parent warrants to SpinCo that, at the time of delivery of any Product EXW as set forth
in Section 5.1: (a) Parent will have title to such Product, free and clear of all liens and encumbrances; (b) such Product will meet the Specifications for the applicable Product SKU in all material respects; and (c) such Product will
have been manufactured, handled, stored and transported in all material respects in accordance with applicable Laws. 
 7.2 Warranty
Claims. Claims for any failure of a Product to meet the warranties set forth in Section 7.1 (such failure, a “Nonconformance”), which Nonconformance is reasonably capable of being detected by visual inspection, shall be
made by SpinCo in writing within sixty (60) days following delivery of the applicable Product EXW as set forth in Section 5.1. Claims for Nonconformance that cannot reasonably be detected through visual inspection (“Latent
Nonconformance”), shall be made by SpinCo in writing to Parent as soon as practicable, but in no event later than fifteen (15) days after such Latent Nonconformance is detected. Upon Parent’s receipt of such a claim, Parent will
work in good faith with SpinCo to resolve the issue. If the Parties have mutually agreed that there is a Nonconformance or Latent Nonconformance, then, in accordance with Parent’s request, the affected Product shall either be returned to Parent
or destroyed at Parent’s reasonable expense. If no claim is made by SpinCo within the timeframes set forth in this Section 7.2, the Product shall be deemed accepted by SpinCo notwithstanding any Nonconformance. SpinCo shall have the right,
but not an obligation, to perform any confirmatory testing of Products released for delivery to SpinCo as SpinCo deems appropriate. 

  

					
		  	Page 19 of 35	  	

 7.3 Disputes. In the event the Parties disagree as to whether a Product is in
Nonconformance or Latent Nonconformance, the Parties shall discuss in good faith in order to determine, by mutual agreement, whether such Product is in Nonconformance or Latent Nonconformance. If such Product is not in Nonconformance or Latent
Nonconformance, SpinCo shall purchase the Product at the Product Price, irrespective of whether Parent has already replaced same (in which case SpinCo shall pay the Product Price for both the original Product and the replacement Product). 

7.4 Sole Remedy. If any Product for which SpinCo made a warranty claim in accordance with Section 7.2 is in Nonconformance or
Latent Nonconformance, Parent shall, at SpinCo’s option, promptly replace the Product at no additional cost to SpinCo, credit SpinCo’s account in an amount equal to the Product Price of the rejected Product, or refund that sum to SpinCo
within sixty (60) days of SpinCo’s request. The remedy set forth in this Section 7.4 shall be SpinCo’s sole remedy with respect to any Nonconformance or Latent Nonconformance, except (a) as expressly set forth in
Section 11.1 with respect to third-party Claims and (b) as expressly set forth in Section 8.7 with respect to out-of-pocket costs incurred in connection
with recalls of SpinCo Products arising from a Nonconformance. 
 7.5 Warranty Exceptions. The warranties set forth in
Section 7.1 shall not apply to: (a) any Product that, following delivery EXW as set forth in Section 5.1, is misused, neglected, improperly stored or handled, altered, abused or used for any purpose other than the one for which it was
manufactured (including any Non-Conforming Use) or other conditions beyond the control of Parent, its Affiliates or their respective agents; or (b) any Product that, following delivery EXW as set forth in
Section 5.1, suffers any damages or defects caused by unauthorized repair or use of parts or components not provided by Parent or its Affiliates under this Agreement for use in connection with the Product. 

7.6 Delivery of Non-Conforming Product. For purposes of determining whether a Supply Failure has
occurred, any delivery of Product (a) that has been rejected by SpinCo in accordance with Section 7.2, (b) that is deemed to be in Nonconformance or Latent Nonconformance under Section 7.3 and (c) for which Parent has not
delivered replacement Product as set forth in Section 7.4 within the sixty (60)-day period set forth in Section 7.4, shall be deemed to be a failure to deliver such Product, for purpose of the
definitions of “Supply Failure” and “Major Supply Failure,” as applicable, to the extent of such Nonconformance or Latent Nonconformance. 

ARTICLE 8 
 REGULATORY
PROVISIONS 
 8.1 Quality. Parent shall maintain ongoing quality assurance and testing procedures in accordance with, and
sufficient to comply with, the Specifications. Upon either Party’s request following the Effective Date, the Parties will enter into good faith negotiations on commercially reasonable terms of a quality agreement, such quality agreement to
enumerate each Party’s responsibilities related to Product quality control and quality assurance, with a goal of entering into such quality agreement within ninety (90) days of the initial request by a Party. 

  

					
		  	Page 20 of 35	  	

 8.2 Regulatory Responsibility. SpinCo shall be solely responsible for diligently
developing and generating appropriate data for regulatory filings to seek approval to market and sell SpinCo Products and for maintaining all such approvals. 

8.3 Audit of Facility and Records. SpinCo may, at its sole expense, send designated SpinCo employees to Parent’s manufacturing
facility upon reasonable notice, during normal business hours and for a reasonable duration, to audit and inspect the facilities in which the Products are manufactured, as is reasonably necessary to monitor Parent’s compliance with this
Agreement, and Parent will allow such SpinCo employees reasonable access to all manufacturing records for the Products as is reasonably necessary for such purposes; provided that SpinCo shall advise Parent in writing at least thirty
(30) days in advance of the names of SpinCo’s employees and the meeting agenda, and shall provide such representatives with proper identification. No such audit involving SpinCo shall be permitted unless and until the Visit CDA shall have
been executed by SpinCo and delivered to Parent. In no event will SpinCo have the right to access any portion of a facility where Parent manufactures cannula that are not Products or that are not for supply to SpinCo, or conducts any activities that
are proprietary in nature (even if such activities relate to the Products or the manufacturing process therefor). 
 8.4 Government
Inspections. It is understood that foreign or domestic government regulatory authorities may send designated employees of such foreign or domestic government regulatory authorities to Parent’s manufacturing facility to inspect the
facilities in which the Product is manufactured to the extent reasonably necessary in connection with SpinCo’s obtaining and maintaining regulatory approvals for SpinCo Products containing Product, and, upon SpinCo’s reasonable prior
notice to Parent, Parent will allow such foreign or domestic government regulatory authorities reasonable access to all manufacturing records for the Products to the extent reasonably necessary for such purposes, subject to customary obligations of
confidentiality. 
 8.5 Manufacturing Process and Product Changes. Parent shall provide SpinCo with notice of any changes to the
manufacturing process for any Product SKU (which changes may constitute, to the extent provided therein, a change in Materials used in the manufacture of the Product, changes to manufacturing sites, etc.), in each case, as would typically be
provided in accordance with Parent’s usual and customary procedure regarding customer notification of a manufacturing process change as then in effect, and Parent may implement such changes; provided that Parent may not implement any
such change without SpinCo’s consent (not to be unreasonably withheld, conditioned or delayed) if such change would be reasonably likely to require an amendment to any regulatory filing for a SpinCo Product or require the collection of
additional clinical data for a SpinCo Product, in either case, unless such change is required by applicable Laws, in which case Parent will provide SpinCo with reasonable advance notice thereof. Parent may not make any changes to the Specifications
for any Product SKU without SpinCo’s consent (not to be unreasonably withheld, conditioned or delayed), unless such change is required by applicable Laws, in which case Parent will provide SpinCo with reasonable advance notice thereof. 

8.6 Exclusion, Debarment or Suspension. Each Party represents and warrants that it and any person or entity employed or engaged by it,
including its employees, contractors, consultants or agents who will provide Materials or Product in connection with this Agreement (for purposes of this Section 8.6, “Personnel”) are not currently: (a) excluded, debarred,
suspended or otherwise ineligible to participate in federal health care programs as defined in 42 U.S.C. § 1320a–7b or in 

  

					
		  	Page 21 of 35	  	

 
federal procurement or non-procurement activities as defined in Executive Order 12689 (“Ineligible”); (b) debarred pursuant to the Generic
Drug Enforcement Act of 1992, 21 U.S.C. § 335(a), as amended, or any similar state law or regulation (“Debarred”); (c) excluded by the Office of Inspector General pursuant to 42 U.S.C. §
1320a-7, et seq. or any state agency from participation in any federal or state health care program as defined in 42 U.S.C. § 1320a-7 and 42 U.S.C. § 1320a-7b (“Excluded”); and/or (d) otherwise disqualified or restricted by the FDA pursuant to 21 C.F.R. § 312.70 or any other regulatory authority (“Disqualified”). Each
Party represents and certifies that it will not utilize any Ineligible, Debarred, Excluded or Disqualified Personnel to provide any Materials or Product hereunder. During the Term of this Agreement, if either Party or any Personnel becomes
Ineligible, Debarred, Excluded, or otherwise Disqualified, such Party (or the Party whose Personnel becomes Ineligible, Debarred, Excluded, or otherwise Disqualified) shall promptly cease using any such Personnel in connection with this Agreement
and will notify the other Party in writing. 
 8.7 Recall. SpinCo will have the sole discretion to effect and control any recall,
withdrawal, or field correction (each, a “Field Action”) with respect to any SpinCo Product sold on or after the Effective Date. In connection with a Field Action, Parent will reasonably cooperate with responding to SpinCo’s
requests for information or other assistance, and in otherwise effecting such Field Action, to the extent relating to any Product. To the extent reasonably possible, SpinCo will consult with Parent before issuing any press release or otherwise
making any public statement or making any other public (or non-confidential) disclosure (whether or not in response to an inquiry) regarding any Field Action that directly or indirectly references or
implicates Parent. SpinCo will be responsible for communicating with any applicable governmental authorities in connection with a Field Action. SpinCo shall bear all costs and expenses incurred by it and by Parent in connection with any such
Field Action (including with respect to any Field Action caused by any supplier of Raw Materials); provided, however, that if a Field Action results specifically from a Nonconformance (including any Latent Nonconformance), then
(a) SpinCo may exercise its rights set forth in Section 7.4 with respect to such Nonconformance (including any Latent Nonconformance), and (b) Parent shall pay the reasonable out-of-pocket costs incurred by SpinCo in connection with SpinCo’s response to such Field Action, but in no event to exceed [* * *] per twelve (12)-month period. Notwithstanding anything to the contrary
in this Agreement, except as expressly set forth in Section 11.1 with respect to third-party Claims, the foregoing shall be SpinCo’s sole and exclusive remedy with respect to a Field Action. 

ARTICLE 9 

CONFIDENTIALITY 
 9.1
Confidential Information. “Confidential Information” shall mean any information relating to the business, technology, products, processes, customers or suppliers of a Party that is disclosed by or on behalf of such Party (the
“Disclosing Party”) to the other Party (the “Receiving Party”) in accordance with this Agreement, and that is marked as confidential, proprietary, or other similar marking or identification, or is of a type which
would reasonably be expected to be confidential or proprietary by persons in the industry. For clarity, any trade secret of a Party or its Affiliates is such Party’s Confidential Information under this Agreement. Confidential Information may be
written, documentary, recorded, or otherwise fixed in a tangible medium, electronically communicated, or orally or visually communicated, furnished, provided, or disclosed by a Disclosing Party, or acquired by a Receiving Party directly or
indirectly from the Disclosing Party. 
  

	[* * *] =	 [CONFIDENTIAL PORTION HAS BEEN OMITTED BECAUSE IT (I) IS NOT MATERIAL AND (II) WOULD BE
COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. 

  

					
		  	Page 22 of 35	  	

 
The Parties acknowledge that Confidential Information includes terms and conditions of this Agreement (with each Party deemed to be the Receiving Party with respect thereto), and any
communications concerning this Agreement, including forecasts and orders of Products. Any Restricted Confidential Information is the Confidential Information of Parent. 

9.2 Non-Disclosure. The Receiving Party will keep all Confidential Information of the Disclosing
Party strictly confidential and not disclose any Confidential Information to any Person except as expressly set forth in this Agreement. The Receiving Party may disclose the Confidential Information only to its Representatives who:
(i) reasonably need to know the Confidential Information for purposes of performing under this Agreement, (ii) are obligated (by binding agreement or professional obligation) not to disclose the Confidential Information, and
(iii) understand the confidential nature of the Confidential Information. The Receiving Party agrees that it shall use commercially reasonable methods, at least as stringent as the methods it uses to protect its own confidential information of
like kind, to maintain and cause its Representatives to maintain the confidentiality of the Confidential Information. All Restricted Confidential Information will also be subject to the restrictions set forth in Section 5.3 and, notwithstanding
anything to the contrary in this Agreement, may not be disclosed by SpinCo to any third party without Parent’s express written consent or to any employee of SpinCo that does not have a need to access or a need to know such Restricted
Confidential Information in order to carry out obligations or exercise express rights of SpinCo under this Agreement. In addition, all employees of SpinCo that are permitted access to, or to whom disclosure is made of, Restricted Confidential
Information must, prior to and as of such access or disclosure, have in effect valid, enforceable agreements with SpinCo with confidentiality and non-use provisions at least as strict as those under this
Agreement. 
 9.3 Protection of Confidential Information Legends. The Receiving Party may not modify or delete any intellectual
property or proprietary rights legend appearing in the Disclosing Party’s Confidential Information. 
 9.4 Confidentiality
Exceptions. Subject to Section 13.7(a), the Receiving Party’s obligations of confidentiality with respect to Confidential Information shall not apply to any information that: 

(a) is or becomes publicly known at or after the time of disclosure by a Disclosing Party, through no wrongful act of the Receiving Party,
including disclosure by the Receiving Party or any of its Affiliates or any of their respective Representatives in violation of this Agreement; or 

(b) is rightfully received by the Receiving Party from a third party, which third party is not itself bound by a confidentiality obligation or
other contractual, legal or fiduciary obligation of confidentiality with respect to such Confidential Information; or 
 (c) is independently
developed by the Receiving Party independent of any Confidential Information of the other Party or its Affiliates, such independent development being performed solely by persons not having access whatsoever to the other Party’s Confidential
Information, as evidenced by contemporaneous written evidence of same. 

  

					
		  	Page 23 of 35	  	

 9.5 Disclosure to Government. If the Receiving Party is required by a court or
judicial or governmental authority of competent jurisdiction to disclose Confidential Information, where allowable by law, the Receiving Party shall provide prompt written notice to the Disclosing Party of such required disclosure so as to enable
the Disclosing Party to resist any such required disclosure, to obtain suitable protection regarding such required disclosure (including a protective order), or otherwise take steps to protect the confidentiality of the Confidential Information, and
shall cooperate with the Disclosing Party in connection therewith. In the event that the Disclosing Party fails to receive suitable protection (including a protective order) in a timely manner and the Receiving Party reasonably determines that it is
required to disclose or provide such Confidential Information, then the Receiving Party may thereafter disclose or provide only that portion of the Confidential Information to the extent required by law, and the Receiving Party shall promptly
provide the Disclosing Party with a copy of the Confidential Information so disclosed, in the same form and format so disclosed, together with a list of all persons to whom such Confidential Information was disclosed, in each case to the extent
legally permitted. 
 9.6 Certain Public Disclosures. If a Party determines in good faith that it is required by applicable Law to
publicly file this Agreement or otherwise disclose the terms of this Agreement with a governmental authority, including public filings pursuant to securities laws or the rules of a stock exchange on which the securities of the Disclosing Party are
listed (or to which an application for listing has been submitted), such Disclosing Party shall provide a proposed redacted form of this Agreement or a copy of any other such proposed disclosure, as applicable, to the other Party with a reasonable
amount of time prior to filing or disclosure for the other Party to review and approve such redacted form or disclosure (which approval shall not be unreasonably conditioned, withheld or delayed). The Party making such filing or disclosure shall
submit this Agreement in a manner consistent with the agreed redaction and shall use commercially reasonable efforts to seek confidential treatment for the redacted terms, to the extent such confidential treatment is applicable and reasonably
available consistent with applicable Law. 
 9.7 Return of Confidential Information. All Confidential Information received or
otherwise acquired by the Receiving Party from the Disclosing Party pursuant to this Agreement shall be and remain the Disclosing Party’s property. After a request by the Disclosing Party, the Receiving Party must within thirty (30) days
return or destroy (and cause the return or destruction by its Affiliates and Representatives) all Confidential Information of the Disclosing Party, and promptly certify to such destruction in writing. The Receiving Party may retain one (1) copy
of all such Confidential Information strictly for archival purposes, and to the extent that the Receiving Party’s routine back-up procedures create copies of Confidential Information, subject to the
confidentiality obligations under this Agreement. 
 9.8 No Obligation to Disclose. Nothing herein shall obligate either Party to
disclose to the other Party any particular information. 
 9.9 No Licenses. Nothing herein contained shall be construed as expressly
or impliedly granting any right or license whatsoever to the Receiving Party under any patent, patent application or other proprietary right now or hereafter owned or controlled by the Disclosing Party. Without limiting the foregoing, SpinCo
acknowledges that Parent is not granting any right or license, express or implied, to SpinCo under this Agreement or otherwise in connection with the supply of Product as contemplated under this Agreement with respect to any intellectual property
owned or controlled by Parent. 

  

					
		  	Page 24 of 35	  	

 9.10 Injunctive Relief. If a Party actually breaches, threatens to breach, or would
inevitably breach the terms of this Article 9, such Party acknowledges that the breach may cause the other Party irreparable harm for which a remedy at Law alone may be inadequate. In such a case, the aggrieved Party is entitled to apply for
injunctive relief without any requirement to post a bond or other security or proof of damages. 
 9.11 Notification of Unauthorized
Access. The Receiving Party shall (i) promptly notify the Disclosing Party upon its becoming aware of any unauthorized possession, use, or knowledge of any Confidential Information by any person, any attempt by any person to gain possession
of Confidential Information without authorization, or any attempt to use or acquire knowledge of any Confidential Information without authorization (collectively, “Unauthorized Access”) and (ii) cooperate with the Disclosing
Party, and accept and implement the Disclosing Party’s reasonable recommendations, in any investigation, litigation and prevention of reoccurrences of any Unauthorized Access. 

9.12 No Limitations of Rights. For the avoidance of doubt, nothing in this Agreement is intended to modify, limit or restrict the rights
and obligations of the Parties and their Affiliates, as applicable, under the Separation and Distribution Agreement or any of the other documents to be entered into as contemplated thereby. 

ARTICLE 10 
 COVENANTS OF
SPINCO 
 10.1 Compliance with Laws; Required Notices. SpinCo shall comply with all applicable Laws and orders of any
governmental authority in connection with the performance of this Agreement and the manufacture, marketing, sale and distribution of SpinCo Products. Without limiting the foregoing, SpinCo shall give all notices required in connection therewith.

 10.2 Safety Laws. Without limitation of Section 10.1, SpinCo hereby acknowledges and agrees that many jurisdictions, including
the United States, have in effect laws, rules and/or regulations, including the Needlestick Prevention Act in the United States (the “Safety Laws”) mandating or recommending the use of protection technologies in connection with drug
delivery devices and containers (collectively, the “Safety Products”). SpinCo has been and will be solely responsible for making its own analysis of such Safety Products and compliance with such Safety Laws. 

10.3 Product Testing and Validation. All Products supplied by Parent under this Agreement are supplied on the condition that it is the
sole responsibility and duty of SpinCo to evaluate, test and validate Products, through stability studies and otherwise, to assure that the Products are compatible and appropriate for use with the applicable SpinCo Products, including SpinCo’s
processing and packaging methods. SpinCo is solely responsible for assuring the sterility of the SpinCo Product (including the Product) when ultimately sold or distributed by SpinCo. 

10.4 Validating Processes. SpinCo also has been and will be solely responsible for designing and validating its processes relating to or
affecting the Product and SpinCo Product, including all such processes relating to the filling, handling, storing, or packaging of Product or SpinCo Product by SpinCo and its contractors. 

  

					
		  	Page 25 of 35	  	

 10.5 Non-Conforming Use. SpinCo shall not,
and shall ensure that its Affiliates and third party manufacturers of SpinCo Products do not, engage in any Non-Conforming Use with respect to any Product. SpinCo shall be responsible for any breach by any
such Affiliate or manufacturer of such restrictions. If, notwithstanding the foregoing, SpinCo or any of its Affiliates or third party manufacturers, or transferees of SpinCo Product from any of the foregoing, engages in a Non-Conforming Use, SpinCo shall, as between Parent and SpinCo, assume all risk and responsibility associated with such Non-Conforming Use. 

10.6 Compliance with Export Laws and Regulations. The Products are subject to the laws and regulations of the United States, including
the U.S. Export Administration Regulations (collectively, “U.S. Laws”), and accordingly: 
 (a) In conducting its activities
under this Agreement, including directly or indirectly selling, reselling, diverting, leasing, disclosing, transferring, exporting or reexporting (collectively, “Transferring”) any Products or SpinCo Products, as applicable, SpinCo
agrees to comply fully with all applicable U.S. Laws as well as all applicable export control laws and regulations of any other foreign government (collectively, “Export Control Laws”). 

(b) SpinCo expressly agrees that it shall not directly or indirectly Transfer Products or SpinCo Products to any destination, entity or
individual in violation of any Export Control Laws. 
 (c) SpinCo is responsible for obtaining any necessary export authorizations under the
Export Control Laws with respect to the Transfer of Products or SpinCo Products. 
 (d) SpinCo attests that the Products and SpinCo Products
will not be used directly or indirectly in the development, production or proliferation of weapons of mass destruction (nuclear, chemical, or biological) or missile delivery systems, and/or in terrorist activities. Further, SpinCo will comply with
all applicable U.S. Laws, including Part 744 of the U.S. Export Administration Regulations, and other government laws and regulations restricting exports to Persons or countries engaging in any of the above activities. It is SpinCo’s
responsibility to ensure that any party to which it Transfers Products or SpinCo Products is not involved in any such activities. 
 (e)
SpinCo agrees that it will comply with all conditions and destination control statements set forth on the invoice, bill of lading or other documents accompanying the shipment of Products and will notify its Representatives, agents and distributors,
customers, and any other person to which it transfers Products or SpinCo Products of the restrictions set forth in this Section 10.6. 

10.7 Customer Complaints. If SpinCo receives a complaint from a customer or user with respect to any SpinCo Product, which complaint
appears to have a connection to a Product incorporated into such SpinCo Product, SpinCo will promptly provide notice thereof to Parent and cooperate with Parent to fully evaluate the complaint and its related circumstances. The Parties shall
cooperate reasonably in responding thereto. 

  

					
		  	Page 26 of 35	  	

 ARTICLE 11 

INDEMNIFICATION 
 11.1
SpinCo’s Indemnification. Parent shall indemnify, defend and hold harmless the SpinCo Indemnitees from and against any and all Third-Party Claims to the extent arising out of or relating to: (i) any breach of this
Agreement by Parent or its Affiliates or Representatives; (ii) any actual or alleged infringement or violation of any patent, trade secret, or other intellectual property or proprietary right of any third party as a result of Parent’s
manufacturing process with respect to any Product, except to the extent that such infringement or violation arises from Parent’s use of information, technology or instructions provided by a SpinCo Indemnitee; or (iii) any bodily injury or
death resulting from the Nonconformance (including any Latent Nonconformance) of any Product, except, in each case ((i) through (iii)), to the extent that SpinCo is obligated to indemnify Parent for such Claims pursuant to Section 11.2. 

11.2 Parent’s Indemnification. SpinCo shall indemnify, defend and hold harmless the Parent Indemnitees from and
against any and all third-party Claims to the extent arising out of or relating to: (i) any breach of this Agreement by SpinCo or its Affiliates or Representatives; (ii) any Non-Conforming Use;
(iii) the sale, distribution, supply, use or operation of any SpinCo Product, including any claims resulting from (a) filling, storing, packaging, testing, using or selling any SpinCo Product or relating to the adequacy of the labeling,
warnings and instructions with respect to any SpinCo Product, or (b) any actual or alleged infringement or violation of any patent, trade secret, or other intellectual property or proprietary right of any third party as a result of the
development or manufacture of a SpinCo Product; or (iv) any needlestick injury or similar damage sustained or alleged by any Person involved in the handling, shipping, manufacture, assembly, sale, distribution, supply, use or operation of any
Product (on or after delivery of such Product EXW as set forth in Section 5.1) or any SpinCo Product and/or any failure or alleged failure of the Product, any SpinCo Product or the assembly, selling, distribution or use of either of the
foregoing to comply with any Safety Law then in effect, including any recall or removal of any Product, any SpinCo Product or any component thereof ordered as a result of any such alleged failure to comply, except, in each case ((i) through (iv)),
to the extent that Parent is obligated to indemnify SpinCo for such Claims pursuant to Section 11.1. 
 11.3 Indemnification
Procedures. Upon the filing of any such Claim or suit, the Indemnitee shall promptly notify the Indemnifying Party thereof, shall give full information and reasonable assistance in the defense or settlement of such Claim or suit and shall permit
such Indemnifying Party, at its cost, to control the defense of such Claim or suit; provided, however, that the Indemnitee may, at its own expense, retain such additional attorneys as it may deem necessary; and provided,
further, that any delay in providing such notice shall not relieve the Indemnifying Party of any of its obligations under this Article 11 except to the extent the Indemnifying Party is materially prejudiced by such delay. The Indemnifying
Party and its attorneys shall permit the Indemnitee’s attorneys to reasonably observe and/or participate in the defense of such Claims or suits. The Indemnifying Party shall have the right, after consultation with the Indemnitee, to resolve and
settle any such Claims or suits, provided that, in no event may the Indemnifying Party compromise or settle any such Claim in a manner that admits fault or negligence on the part of the Indemnitee, does not contain an applicable release of
Claims, or includes injunctive relief or any damages other than monetary damages, in each case, without the prior written consent of the Indemnitee. The Indemnifying Party shall not be responsible for any settlement or other disposition or agreement
reached with respect to any such Claim or suit unless the Indemnifying Party shall have given its prior written consent with respect to such settlement or other disposition or agreement. 

  

					
		  	Page 27 of 35	  	

 11.4 Third-Party Claims Only. For the avoidance of doubt, the Parties acknowledge and
agree that the indemnity provisions under this Article 11 apply solely to third-party claims, judgments, damages, losses, liabilities, suits, costs, and expenses (including the reasonable attorneys’ fees and court costs of such third party) and
shall not apply to any direct claims that either Party may have against the other Party. 
 ARTICLE 12 

REPRESENTATIONS AND WARRANTIES; LIMITATION OF LIABILITY 

12.1 General Representations and Warranties. Each Party hereby represents and warrants to the other Party as of the Effective Date as
follows: 
 (a) Such Party (i) has the power and authority and the legal right to enter into this Agreement, and (ii) has taken all
necessary action on its part required to authorize the execution and delivery of this Agreement and the performance of its obligations hereunder. 

(b) Such Party (i) is duly formed and in good standing under the Laws of the jurisdiction of its formation and (ii) has the power and
authority and the legal right to perform its obligations hereunder. 
 (c) This Agreement has been duly executed and delivered on behalf of
such Party and constitutes a legal, valid and binding obligation of such Party and is enforceable against it in accordance with its terms, subject to the effects of bankruptcy, insolvency or other similar Laws of general application affecting the
enforcement of creditor rights and judicial principles affecting the availability of specific performance and general principles of equity, whether enforceability is considered in a proceeding at law or in equity. 

(d) The execution and delivery of this Agreement and the performance of such Party’s obligations hereunder (i) do not and will not
conflict with or violate any requirement of applicable Laws or any provision of the articles of incorporation, bylaws or any other constitutive document of such Party and (ii) do not and will not conflict with, violate, or breach, or constitute
a default or require any consent under, any contract or order by which such Party is bound, except, in the case of subsection (ii) of this section (d), for such conflicts, violations, breaches and defaults, and such consents the failure of
which to obtain, would not materially and adversely affect the ability of such Party to perform its obligations under this Agreement. 
 12.2
Covenant. Each Party shall (i) comply in all material respects with all applicable Laws related to such Party’s activities to be performed under this Agreement and (ii) obtain and maintain all necessary consents of all
governmental authorities required to be obtained by such Party in connection with the performance of its obligations hereunder. 

  

					
		  	Page 28 of 35	  	

 12.3 DISCLAIMER. THE REPRESENTATIONS AND WARRANTIES SET FORTH IN THIS ARTICLE 12,
TOGETHER WITH THE LIMITED PRODUCT WARRANTY SET FORTH IN SECTION 7.1, SHALL BE IN LIEU OF ALL OTHER WARRANTIES, AND EACH PARTY HEREBY DISCLAIMS ALL OTHER WARRANTIES, EXPRESS OR IMPLIED, INCLUDING WARRANTIES OF MERCHANTABILITY OR FITNESS FOR A
PARTICULAR PURPOSE. PARENT EXPRESSLY DISCLAIMS ANY REPRESENTATIONS AND WARRANTIES REGARDING THE PRODUCTS EXCEPT FOR THE LIMITED PRODUCT WARRANTY SET FORTH IN SECTION 7.1. EACH OF SPINCO AND PARENT HEREBY ACCEPTS SUCH DISCLAIMERS. 

12.4 EXCEPT WITH RESPECT TO A BREACH OF EITHER PARTY WITH RESPECT TO ITS OBLIGATIONS UNDER THIS AGREEMENT REGARDING CONFIDENTIAL INFORMATION
(INCLUDING, IN THE CASE OF SPINCO, BREACH OF ITS OBLIGATIONS REGARDING RESTRICTED CONFIDENTIAL INFORMATION), THIRD PARTY CLAIMS UNDER SECTION 11.1 OR 11.2, NEITHER PARTY SHALL BE LIABLE UNDER THIS AGREEMENT FOR ANY SPECIAL, INDIRECT, PUNITIVE,
CONSEQUENTIAL OR INCIDENTAL DAMAGES, INCLUDING LOSS OF ACTUAL OR ANTICIPATED PROFITS OR REVENUES, LOSS BY REASON OF SHUTDOWN, LOSS OF USE, LOSS OF ACCRUING INTEREST, NONOPERATION OR INCREASED EXPENSE OF MANUFACTURING OR OPERATION, DELAY, OR ANY
DAMAGES ARISING IN CONNECTION WITH THE RECONSTRUCTION OF OR LOSS OF OTHER PROPERTY OR EQUIPMENT OR ANY LOSS OF REPUTATION OR PUBLIC IMAGE. EXCEPT AS EXPRESSLY SET FORTH IN SECTION 11.1 OR TO THE EXTENT CAUSED BY THE GROSS NEGLIGENCE OR WILLFUL
MISCONDUCT OF PARENT OR ANY OF ITS AFFILIATES, PARENT SHALL NOT BE LIABLE FOR ANY DAMAGES ARISING FROM (a) ANY NON-CONFORMING USE OF A PRODUCT, (b) CLAIMS OF THIRD PARTIES FOR INJURY, DEATH OR
PROPERTY DAMAGE SUFFERED AS A RESULT OF THE USE OF ANY PRODUCT OR SPINCO PRODUCT, OR (c) FAILURE TO WARN, OR TO ADEQUATELY WARN, AGAINST THE DANGERS OF, OR FAILURE TO INSTRUCT, OR TO ADEQUATELY INSTRUCT, ABOUT THE SAFE AND PROPER USE OF, ANY
SPINCO PRODUCT; PROVIDED THAT, FOR CLARITY, IN NO EVENT SHALL PARENT HAVE ANY LIABILITY FOR A SPINCO PRODUCT THAT DOES NOT CONTAIN A PRODUCT. 

12.5 NOTWITHSTANDING ANYTHING ELSE TO THE CONTRARY SET FORTH IN THIS AGREEMENT, THE MAXIMUM LIABILITY OF PARENT IN RESPECT OF THIS AGREEMENT
FOR ALL CLAIMS, WHETHER IN CONNECTION WITH A WARRANTY CLAIM, A RECALL OR REMOVAL (SUBJECT TO SECTION 8.7), AN INDEMNITY CLAIM UNDER ARTICLE 11 OR OTHERWISE, A COMBINATION THEREOF, OR OTHERWISE AND WHETHER ARISING UNDER CONTRACT, WARRANTY, TORT
(INCLUDING NEGLIGENCE), STRICT LIABILITY, PRODUCT LIABILITY, A COMBINATION THEREOF, OR ANY OTHER THEORY OF LIABILITY OR INDEMNIFICATION, ARISING FROM AN ACT OR OMISSION IN ANY FISCAL YEAR, SHALL NOT EXCEED, IN THE AGGREGATE, AN AMOUNT EQUAL TO
[* * *] PERCENT ([* * *]%) OF THE TOTAL REVENUES ACTUALLY RECEIVED BY PARENT FROM SPINCO UNDER THIS AGREEMENT IN THE IMMEDIATELY PRIOR FISCAL YEAR (THE “LIABILITY CAP”); PROVIDED, HOWEVER, THAT THE
LIABILITY CAP FOR THE FIRST FISCAL YEAR OF THE TERM SHALL BE AN AMOUNT EQUAL TO [* * *] PERCENT ([* * *]%) OF THE TOTAL REVENUES ANTICIPATED TO BE RECEIVED BY PARENT FROM SPINCO UNDER THIS AGREEMENT IN THE YEAR 1 BASED ON THE 2022 BASE
FORECAST; AND PROVIDED, FURTHER, THAT THE FOREGOING LIMITATION SHALL NOT APPLY TO ANY CLAIMS RESULTING FROM PARENT’S INTENTIONAL FAILURE 
  

	[* * *] =	 [CONFIDENTIAL PORTION HAS BEEN OMITTED BECAUSE IT (I) IS NOT MATERIAL AND (II) WOULD BE
COMPETITIVELY HARMFUL IF PUBLICLY DISCLOSED. 

  

					
		  	Page 29 of 35	  	

 
TO SUPPLY PRODUCTS (PROVIDED THAT PARENT IS REASONABLY ABLE TO SO SUPPLY), GROSS NEGLIGENCE OR WILLFUL MISCONDUCT. EACH PARTY FURTHER ACKNOWLEDGES THAT ANY RIGHT OF RECOVERY BY SUCH
PARTY’S INSURER IS HEREBY WAIVED AND SUCH PARTY’S INSURER SHALL NOT HAVE ANY OTHER RECOURSE AGAINST THE OTHER PARTY FOR DAMAGES PAID UNDER SUCH FIRST PARTY’S INSURANCE POLICIES FOR LIABILITIES ARISING IN CONNECTION WITH THIS
AGREEMENT. NOTWITHSTANDING THE FOREGOING, THIS SECTION 12.5 SHALL NOT APPLY WITH RESPECT TO DIRECT CLAIMS FOR NONCONFORMANCE (INCLUDING LATENT NONCONFORMANCE), THE SOLE AND EXCLUSIVE REMEDY FOR WHICH IS SET FORTH IN SECTION 7.4, OR CLAIMS FOR OUT-OF-POCKET COSTS IN CONNECTION WITH A RECALL CAUSED BY NONCONFORMANCE (INCLUDING LATENT NONCONFORMANCE), THE SOLE AND EXCLUSIVE REMEDY FOR WHICH IS SET FORTH IN SECTION
8.7. 
 ARTICLE 13 

TERM 
 13.1 Term.
Subject to the terms and conditions herein, this Agreement shall commence on the Effective Date and shall continue in perpetuity unless and until terminated in accordance with the provisions of this Article 13 (the “Term”). 

13.2 Automatic Termination. This Agreement shall terminate automatically, immediately following a
thirty-six (36) month wind-down period, if SpinCo submits a forecast pursuant to Section 4.1 for Year 6 on any Fiscal Year thereafter that fails to satisfy any of the applicable Purchase Commitments
as set forth in Section 2.2(b)(ii), provided that no such automatic termination shall occur if, at the time of such failure, SpinCo is excused from compliance with such Purchase Commitment(s) based on a Major Supply Failure as set forth
in Section 6.4. 
 13.3 Termination for Convenience. 

(a) Parent may terminate this Agreement for any reason or no reason by providing at least thirty-six
(36) months’ written notice to SpinCo, with such termination to be effective no earlier than ten (10) years after the Effective Date. 

(b) SpinCo may terminate this Agreement for any reason or no reason any time after the Effective Date by providing at least thirty-six (36) months’ written notice to Parent, with such termination to be effective no earlier than five (5) years after the Effective Date. 

13.4 Termination for Material Breach. Either Party may terminate this Agreement, upon written notice to the other Party if the other
Party materially breaches this Agreement, unless the breaching Party cures such material breach within sixty (60) days of written notice thereof from the non-breaching Party to the breaching Party (which
period shall be thirty (30) days in the case of a failure to pay). 

  

					
		  	Page 30 of 35	  	

 13.5 Termination for Bankruptcy. Either Party may terminate this Agreement
immediately upon written notice by one Party to the other, if the other Party makes an assignment for the benefit of creditors, has a receiver appointed for it or any of its assets, or files or has filed against it a petition under the Bankruptcy
Code of 1978, as amended, 11 U.S.C. § 101 et seq., or under any state insolvency laws providing for the relief of debtors, and such petition is not dismissed within sixty (60) days of its filing. 

13.6 Termination for Change of Control. In the event that SpinCo consummates a Change of Control, then Parent will have
the right to terminate this Agreement in response to the consummation of the Change of Control by SpinCo, which right may be exercised by Parent in its sole discretion. Such termination right will be exercisable once the notice to Parent of the
consummation of the Change of Control has been provided (which notice shall be provided promptly). 
 13.7 Effects of Termination.

 (a) The confidentiality and non-use obligations of the Receiving Party with respect to the
Disclosing Party’s Confidential Information shall survive indefinitely, notwithstanding any termination of this Agreement, for so long as such information continues to satisfy the definition of Confidential Information under this Agreement;
provided that each Party’s confidentiality and non-use obligations under this Agreement with respect to trade secrets of the other Party or its Affiliates shall be perpetual for as long as such
information derives independent economic value, actual or potential, from not being generally known to or readily ascertainable through proper means by the public and are the subject of efforts that are reasonable under the circumstances to maintain
secrecy. 
 (b) Promptly following any termination of this Agreement (but no more than ninety (90) days following such termination),
SpinCo will, at its sole cost, ship to Parent any and all Cartridges that are in SpinCo’s or its Affiliates’ or third party manufacturers’ possession or control at such time. 

13.8 Survival. Upon the effective date of any termination of this Agreement, this entire Agreement shall forthwith become void and all
obligations of the Parties (and their respective officers, directors and equity holders) hereunder shall terminate, except that the rights and obligations specified in Article 1 (Definitions), Section 2.1 (Purchase and Sale of Product) (with respect
to the last sentence), Section 2.3 (Alternative Suppliers), Section 3.5 (Capital Cost Recovery), Section 4.8 (Annual Reconciliation), Section 4.9 (Conflicts), Article 5 (Shipment and Delivery: Invoices) (with respect to Section 5.1 and 5.2, solely
with respect to Product ordered prior to termination of this Agreement), Article 7 (Product Warranty) (with respect to Product ordered prior to termination of this Agreement), Section 8.3 (Audit of Facility and Records) (with respect to Product
ordered prior to termination of this Agreement), Section 8.4 (Government Inspections) (with respect to Product ordered prior to termination of this Agreement), Section 8.7 (Recall), Article 9 (Confidentiality), Article 10 (Covenants of SpinCo),
Article 11 (Indemnification), Article 12 (except for Section 12.1 (General Representations and Warranties)), Section 13.7 (Effects of Termination), Section 13.8 (Survival), Article 14 (Force Majeure) and Article 15 (Miscellaneous), and those rights
and obligations that have accrued prior to termination or expiration, will survive such event; provided, however, that nothing herein shall relieve any Party from liability for any breach of this Agreement and provided,
further, that no such termination or expiration shall relieve SpinCo of its obligation to purchase Products for which Purchase Orders have been confirmed by Parent. 

ARTICLE 14 
 FORCE
MAJEURE 
 14.1 Excused Delay. Notwithstanding anything to the contrary in this Agreement, any Force Majeure shall not be
considered a breach of this Agreement, shall not give rise to a right of termination with respect to a Product SKU under Section 6.4(e) or 13.4, and the time required for performance shall be extended for a period equal to the period of such
delay. Force Majeure shall include acts of God, acts of the public enemy, war, terrorism, insurrections, riots, injunctions, pandemics, epidemics, embargoes, fires, explosions, floods, tornadoes, violent wind damage, changes in applicable Law or
government orders, or other unforeseeable causes beyond the reasonable control, and without the fault or negligence of, the Party so affected. The Party that is subject to a Force Majeure affecting this Agreement shall give prompt written notice to
the other Party of such Force Majeure and shall take commercially reasonable steps to seek to mitigate the effects of such Force Majeure. 

  

					
		  	Page 31 of 35	  	

 14.2 Notice and Allocation. In addition to and not in lieu of the terms and
conditions above, if a Force Majeure causes a shortage of Raw Materials or a shortage of Product, Parent shall equitably allocate such Raw Materials or Product among all of Parent’s requirements with respect to such Raw Materials or Products,
based on SpinCo’s usage and Parent’s usage for the twelve (12)-month period prior to such Force Majeure. 
 ARTICLE 15 

MISCELLANEOUS 
 15.1
Assignment. This Agreement is not assignable, delegable, sublicensable, or otherwise transferable by SpinCo in whole or in part, (including by any transaction that may be deemed to be direct or indirect transfer or assignment by operation of
law), without the prior written consent of Parent, which consent may be provided in the sole discretion of Parent. Any such assignment, delegation, sublicense or transfer by SpinCo without Parent’s prior written consent will be null, void,
and invalid, and the purported assignee, delegee, sublicensee or transferee will not acquire any rights nor assume any duties under this Agreement. Notwithstanding the foregoing, in the event of an assignment by SpinCo with the written consent
of Parent, this Agreement shall be binding upon and inure to the benefit of the permitted successors and assigns of SpinCo, provided that any such assignee expressly agrees in writing to be bound by the obligations of SpinCo in this
Agreement. This Agreement is not assignable, delegable, sublicensable, or otherwise transferable by Parent to a Third Party in whole or in part; provided that Parent may assign this Agreement in connection with the sale of all of substantially
all of Parent’s assets to which this Agreement relates if such assignee expressly agrees in writing to be bound by the obligations of Parent in this Agreement. 

15.2 Third-Party Rights. Nothing in this Agreement, express or implied, is intended to or shall confer on any third party, any rights,
remedies, obligations or liabilities under or by reason of this Agreement or the transactions contemplated hereby. 
 15.3 Use of
Affiliates. Notwithstanding the foregoing, Affiliates of SpinCo may submit Purchase Orders hereunder, and Affiliates or third-party contractors of Parent may perform all or part of the supply obligations of Parent hereunder without the prior
written consent of the other Party. Each Party will require and cause any Affiliate performing obligations on its behalf under this Agreement to comply with the terms and conditions of this Agreement. 

15.4 Fully Incorporated. This Agreement, the Separation and Distribution Agreement and the other Ancillary Agreements together with any
Schedules and/or Exhibits attached hereto and thereto, contain the entire agreement between the Parties hereto with respect to the subject matter of this Agreement, and supersede all previous written or oral negotiations, commitments, transactions,
or understandings with respect thereto, whether oral or written, express or implied. 
 15.5 Modifications. This Agreement may only be
modified by a written instrument, executed by duly constituted officers of both Parties hereto. 

  

					
		  	Page 32 of 35	  	

 15.6 Insurance. During the Term and for not less than two (2) years thereafter,
each Party shall maintain commercial general liability insurance. This insurance shall include product liability and cover claims arising out of or relating to all activities and products contemplated under this Agreement. Such insurance shall
provide a minimum limit of liability of not less than $5,000,000 per occurrence and $15,000,000 in the aggregate, provided that such insurance limits shall not limit either Party’s legal liability hereunder. 

15.7 Relationship. The relationship created by this Agreement shall be strictly that of independent contractors. Neither Party is hereby
constituted an agent or legal representative of the other Party for any purpose whatsoever and is granted no right or authority hereunder to assume or create any obligation, express or implied, or to make any representation, warranties or
guarantees, except as are expressly granted or made in this Agreement. 
 15.8 Notice. Any notice required or permitted to be given
hereunder shall be sufficient if in writing and (a) delivered in person or by express delivery or courier service, (b) sent by e-mail without receipt of a delivery failure, or (c) deposited in
the mail registered or certified first class, postage prepaid and return receipt requested; provided that any notice given pursuant to clause (b) is also confirmed by the means described in clause (a) or (c) to such address of the
Party set forth below or to such other place or places as such Party from time to time may designate in writing in compliance with the terms hereof. Each notice shall be deemed given when so delivered personally, or sent by electronic transmission,
or, if sent by express delivery or courier service one (1) business day after being sent, or if mailed, five (5) business days after the date of deposit in the mail. A notice of change of address shall be effective only when done in
accordance with this Section 15.8. 
 if to Parent: 

Becton, Dickinson and Company 
 1
Becton Drive 
 Franklin Lakes, New Jersey 07417 

	 	Attention:	 Joseph LaSala 

Chief Counsel - Transactions/M&A 

	 	E-mail:	 joseph_lasala@bd.com 

if to SpinCo at:                 

SpinCo 
 Embecta Corp. 

300 Kimball Drive 
 Parsippany,
New Jersey 07054 

	 	Attention:	 Jeff Mann 

Senior Vice President, General Counsel, 

Head of Corporate Development and Corporate Secretary 

	 	E-mail:	 jeff.mann@bd.com; jeff.mann@embecta.com 

  

					
		  	Page 33 of 35	  	

 15.9 Waiver. A waiver by either Party or a breach of any of the terms of this
Agreement by the other Party shall not be deemed a waiver of any subsequent breach of the terms of this Agreement. 
 15.10 Dispute
Resolution. The Parties shall attempt in good faith to resolve any dispute arising out of or relating to this Agreement promptly by negotiations. Either Party may give the other Party written notice of any dispute hereunder not resolved in the
normal course of business. Within thirty (30) days following such delivery of such notice, executives of both Parties shall discuss by telephone, video conference or meeting at a mutually acceptable time and place, and thereafter as often as
they reasonably deem necessary, to exchange relevant information, and to attempt to resolve such dispute. If the matter has not been resolved within sixty (60) days following the disputing Party notice, or if the Parties fail to discuss or meet
within the thirty (30)-day period, then either Party may pursue any other available remedies in connection therewith. Nothing herein shall prevent a Party from pursuing immediate equitable relief, if not
pursuing that relief could lead to irreversible damage or bodily injury to a Party or third party. 
 15.11 Choice of Law. The rights
and obligations of the Parties shall be governed by, and this Agreement shall be interpreted, construed and enforced in accordance with, the laws of the State of New York, excluding its conflict of laws rules to the extent such rules would apply the
law of another jurisdiction. 
 15.12 Choice of Venue. Any judicial proceeding brought against any of the Parties to this Agreement or
any dispute arising out of this Agreement or related hereto may be brought in the courts of the State of New York, or in the United States District Court for the Southern District of New York, and, by execution and delivery of this Agreement, each
of the Parties to this Agreement accepts the exclusive jurisdiction of such courts, and irrevocably agrees to be bound by any judgment rendered thereby in connection with this Agreement. The foregoing consents to jurisdiction shall not constitute
general consents to service of process in the State of New York for any purpose except as provided above and shall not be deemed to confer rights on any Person other than the Parties to this Agreement. Each of the Parties to this Agreement agree
that service of any process, summons, notice or document by U.S. mail to such Party’s address for notice hereunder shall be effective service of process for any action, suit or proceeding in New York with respect to any matters for which it has
submitted to jurisdiction pursuant to this Section 15.12. 
 15.13 Waiver of Jury Trial. Each of the Parties hereto hereby
irrevocably waives its right to a jury trial in connection with any action, proceeding or claim arising out of or relating to this Agreement or any transaction contemplated hereby. 

15.14 Interpretation. Except as otherwise explicitly specified to the contrary, (a) references to a Section, Article, Exhibit or
Schedule means a Section or Article of, or Schedule or Exhibit to this Agreement, unless another agreement is specified, (b) the word “including” (in its various forms) means “including without limitation,” (c) references to
a particular statute or regulation include all rules and regulations thereunder and any predecessor or successor statute, rules or regulation, in each case as amended or otherwise modified from time to time, (d) words in the 

  

					
		  	Page 34 of 35	  	

 
singular or plural form include the plural and singular form, respectively, (e) references to a particular Party include such Party’s successors and assigns to the extent not prohibited
by this Agreement, (f) “extent” in the phrase “to the extent” means the degree to which a subject or other thing extends, and such phrase does not mean simply “if,” (g) the headings contained in this Agreement, in any
Exhibit or Schedule hereto and in the table of contents to this Agreement are for reference purposes only and shall not affect in any way the meaning or interpretation of this Agreement, (h) the words “will” and “shall”
shall be interpreted to have the same meaning, (i) references to “$” shall mean U.S. dollars, and (j) use of the word “or” shall be interpreted in the inclusive sense commonly attributed to the phrase
“and/or.” The Parties acknowledge that each Party has read and negotiated the language used in this Agreement. The Parties agree that, because all Parties participated in negotiating and drafting this Agreement, no rule of construction
shall apply to this Agreement which construes ambiguous language in favor of or against any Party by reason of that Party’s role in drafting this Agreement. 

15.15 Headings. The headings and subheadings herein are inserted for convenience of reference and shall not affect the interpretation of
this Agreement. 
 15.16 Counterparts. This Agreement may be executed in any number of counterparts, each of which once so executed
and delivered shall be deemed an original, but all of which shall constitute but one and the same agreement. 
 15.17 Severability. If
any provision of this Agreement is deemed or held to be illegal, invalid, unenforceable or contrary to any laws or regulations, all other provisions will continue in full force and effect, and the Parties, where possible, will substitute for such
provision a valid and enforceable provision which conforms as nearly as possible with the original intent of the Parties, or such provision shall be limited or eliminated to the minimum extent necessary so that this Agreement shall otherwise remain
in full force and effect and enforceable. 
 (Signatures on next page) 

 

  

					
		  	Page 35 of 35	  	

 IN WITNESS WHEREOF, the Parties have executed this Agreement as of the Effective Date. Each person who
signs this Agreement below represents that such person is fully authorized to sign the Agreement on behalf of the applicable Party.
  

			
	BECTON, DICKINSON AND COMPANY
		
	By:	 	 /s/ Christopher J. DelOrefice

	Name:	 	Christopher J. DelOrefice
	Title:	 	Executive Vice President and Chief Financial Officer
	
	EMBECTA CORP.
		
	By:	 	 /s/ Jacob Elguicze

	Name:	 	Jacob Elguicze
	Title:	 	Chief Financial Officer

 [Signature Page to Cannula Supply Agreement]

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00343-of-00352.parquet"}]]